Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3025271	b-nk	E6/l (e6/l)	2092	5955	0.00%
3025271	b-nk	— (—)	784	1295	100.00%	Distribution not available
3025271	b-nk	E9/l (e6/l)	741	1705	0.00%
3025271	b-nk	E9/l______ (e6/l)	11	14	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1144

2055

3.75

318.31

2.6

2.7

222.14

231.17

e6/l

0.56

972

1690

Other bacterial diseases, including avohilmo

1133

1890

3.79

311.88

3.1

2.5

209.27

245.23

e6/l

4.62

952

1571

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1064

1237

5.10

307.65

2.6

2.5

220.06

239.10

e6/l

1.26

903

1029

Secondary and unspecified malignant neoplasm of lymph nodes

335

127

28.91

307.65

3.0

1.8

221.32

221.01

e6/l

0.01

282

109

Bacterial infection, other or unspecified, including avohilmo

813

1198

5.67

307.65

3.0

2.5

206.31

247.42

e6/l

4.54

706

1025

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

359

247

15.25

307.65

2.9

2.0

219.32

229.42

e6/l

0.25

303

214

Non-Hodgkin lymphoma, all

208

48.61

307.65

3.7

1.4

202.99

203.12

e6/l

0.00

176

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1460

1710

5.86

307.65

2.9

2.5

205.84

247.67

e6/l

6.66

1214

1432

Second line medication for Crohn's disease

822

1785

4.69

307.65

2.6

2.7

196.06

237.68

e6/l

3.82

691

1496

Autoimmune diseases excluding thyroid diseases, strict definition

1165

1602

4.00

307.65

2.7

215.68

243.20

e6/l

2.83

1000

1309

Immunodeficiency with predominantly antibody defects

280

67.09

307.65

2.8

1.9

228.24

237.09

e6/l

0.10

227

Liquid cancers

982

501

19.77

307.65

3.6

2.1

229.43

228.41

e6/l

0.03

842

428

L04AX Other immunosuppressants

796

1735

4.68

307.65

2.7

199.34

236.38

e6/l

2.98

665

1452

Primary_lymphoid and hematopoietic malignant neoplasms

915

434

22.82

307.65

3.7

2.2

232.37

229.67

e6/l

0.07

785

376

Immunodeficiencies

370

126

36.10

307.65

3.0

2.5

234.63

225.09

e6/l

0.18

303

100

Diffuse large B-cell lymphoma, including Hilmo

239

43.05

307.65

2.7

1.6

202.24

200.61

e6/l

0.02

203

L04AA Selective immunosuppressants

508

689

7.69

307.65

3.2

2.9

204.68

233.62

e6/l

1.77

419

567

Other bacterial diseases

1116

1808

4.14

307.65

3.1

2.5

207.32

244.19

e6/l

4.77

939

1505

ILD medications: prednisolone, methylprednisolone, prednisone

1409

1178

6.76

307.65

2.7

2.4

205.95

250.79

e6/l

7.38

1167

979

Influenza and pneumonia

1243

1955

3.97

307.65

2.8

2.6

222.68

230.35

e6/l

0.46

1061

1603

Autoimmune diseases related-to ILD

1040

2083

4.23

307.65

2.9

2.5

211.08

237.49

e6/l

3.12

897

1727

Pneumonias (Asthma/COPD co-morbidities)

1200

1986

4.00

307.65

2.7

2.6

220.03

232.20

e6/l

0.87

1021

1632

First line medication for Crohn's disease

1382

1331

5.67

307.65

2.9

2.6

204.87

254.59

e6/l

7.53

1144

1103

Certain disorders involving the immune mechanism

580

530

11.64

307.65

3.2

2.7

225.04

227.76

e6/l

0.08

480

438

1064

1237

5.10

307.65

2.6

2.5

220.06

239.10

e6/l

1.26

903

1029

Pneumonia, organism unspecified

1051

1816

4.02

307.65

2.7

2.6

223.49

232.24

e6/l

0.49

892

1490

Diffuse large B-cell lymphoma, helper endpoint

239

43.05

307.65

2.7

1.6

202.24

200.61

e6/l

0.02

203

Enlarged lymph nodes

399

315

13.27

307.65

3.1

2.6

239.56

240.54

e6/l

0.02

330

270

Demyelinating diseases of the central nervous system

414

205

22.54

307.65

4.2

2.0

258.49

213.46

e6/l

2.37

358

166

ILD medications: immunosuppressive drugs

1183

1099

10.02

307.65

3.1

2.4

205.12

249.58

e6/l

5.11

997

916

Other diseases of blood and blood-forming organs, wide

475

611

8.10

307.65

3.5

2.6

197.80

235.50

e6/l

2.28

395

516

Diffuse large B-cell lymphoma

239

43.05

307.65

2.7

1.6

202.24

200.61

e6/l

0.02

203

Secondary uncertain malignant neoplasm

366

185

20.94

307.65

3.0

1.9

218.48

229.39

e6/l

0.24

307

161

ILD medications

1584

1242

6.99

307.65

2.9

2.4

213.27

247.28

e6/l

4.10

1308

1027

Bacterial infection, other or unspecified

781

1073

6.27

307.65

3.1

2.4

205.71

248.07

e6/l

4.44

678

927

Liquid cancers, including Hilmo

1016

597

15.79

307.65

3.6

2.1

230.60

229.22

e6/l

0.04

873

513

MS-disease / Multiple Sclerosis

393

160

27.86

307.65

4.2

2.1

263.48

216.71

e6/l

2.13

339

129

Autoimmune diseases excluding thyroid diseases

1203

1661

3.97

307.65

2.7

217.15

243.18

e6/l

2.64

1030

1353

Oral corticosteroids

1337

1558

5.11

307.65

2.4

2.8

211.31

248.62

e6/l

4.92

1121

1315

All pneumoniae

1200

2027

3.90

307.65

2.7

220.13

230.64

e6/l

0.71

1022

1668

Non-follicular lymphoma

419

179

26.04

307.65

3.1

2.3

231.00

223.91

e6/l

0.15

359

152

Transplanted organ and tissue status

328

265

13.32

307.65

6.4

2.4

190.29

216.33

e6/l

0.97

285

209

Non-Hodgkin lymphoma, all, including Hilmo

591

184

35.56

307.65

3.2

1.9

231.59

229.99

e6/l

0.03

504

159

Inflammatory bowel disease treatment related agents

1388

1678

4.65

307.65

2.5

2.8

203.79

245.09

e6/l

6.60

1145

1410

Fever of other and unknown origin

913

1115

7.25

307.65

3.1

2.4

213.79

251.31

e6/l

3.18

782

931

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

785

1615

4.29

285.51

2.7

2.6

230.29

236.19

e6/l

0.25

696

1360

Non-invasive ventilation

441

524

7.46

283.51

2.5

3.1

232.53

238.14

e6/l

0.16

406

434

Septicaemia

553

903

5.69

282.68

3.5

2.4

199.65

244.84

e6/l

4.46

456

770

Abnormal findings on diagnostic imaging of lung

591

1097

5.20

277.71

2.6

2.5

233.25

236.84

e6/l

0.12

528

950

Other septicaemia, including avohilmo

508

815

5.97

275.66

3.4

2.4

200.06

246.97

e6/l

4.21

419

698

Other degenerative diseases of the nervous system

453

456

7.42

268.08

4.0

2.2

251.39

233.15

e6/l

0.73

392

386

Other septicaemia

495

801

5.94

268.00

3.5

2.4

199.80

245.08

e6/l

3.93

408

686

Other demyelinating diseases of the central nervous system

183

27.90

264.51

4.0

2.2

253.72

208.06

e6/l

1.57

152

Other and unspecified immunodeficiencies with predominantly antibody defects

146

70.41

260.90

3.0

1.4

218.79

202.30

e6/l

0.19

113

ILD medications: azathioprine

263

248

10.96

243.16

2.5

2.1

146.59

242.20

e6/l

7.43

216

206

Nonhereditary hypogammaglobulinemia

131

79.56

239.46

2.8

1.7

217.58

206.47

e6/l

0.11

107

Explicit Sepsis, including avohilmo

581

1142

4.69

238.96

3.4

2.6

198.66

244.72

e6/l

5.13

479

974

General symptoms and signs

970

1327

3.70

237.72

2.8

2.5

215.38

245.52

e6/l

2.65

810

1108

Explicit Sepsis

570

1118

4.73

236.77

3.4

2.6

198.19

244.17

e6/l

5.02

469

954

Bacterial pneumonia (organism specified)

559

1086

4.74

232.78

2.5

2.7

231.54

231.57

e6/l

0.00

477

929

Rare circulating lymphoid malignancy, including Hilmo

154

31.48

231.31

5.5

2.3

214.19

227.65

e6/l

0.16

123

Dental caries

398

619

6.21

224.88

3.3

2.5

209.98

252.62

e6/l

2.45

318

531

Anaemias

366

287

8.36

221.96

3.5

2.4

174.91

240.71

e6/l

6.13

297

231

Kela reimbursement Agammaglobulinemia (D80-84)

121

73.16

215.47

4.0

1.3

191.28

231.47

e6/l

0.56

GASTRO-related operations

689

777

4.49

213.88

3.1

2.3

203.07

253.56

e6/l

5.90

568

595

Any gastric operation

689

777

4.49

213.88

3.1

2.3

203.07

253.56

e6/l

5.90

568

595

Infections, IBD-co-morbidities

280

184

11.00

213.76

3.7

2.5

221.07

227.60

e6/l

0.12

241

145

Asthma (only as main-diagnosis)

619

745

4.69

211.81

1.9

2.7

244.64

248.75

e6/l

0.12

507

616

Asthma (only as main-diagnosis), excluding more controls

611

721

4.73

210.02

1.9

2.7

242.97

250.13

e6/l

0.22

500

595

Bacterial pneumoniae

475

844

5.02

209.51

2.3

2.6

233.37

237.08

e6/l

0.11

398

708

Agranulocytosis

254

283

9.42

208.64

3.9

2.6

175.97

226.59

e6/l

2.62

210

239

Bacterial pneumonia, not elsewhere classified

453

783

5.16

206.21

2.3

2.6

234.80

238.93

e6/l

0.12

377

662

Certain infectious and parasitic diseases

828

1134

3.69

202.68

2.8

2.4

218.05

247.44

e6/l

2.15

682

947

Autoimmune diseases

1029

1675

3.15

201.37

2.7

212.26

243.52

e6/l

3.57

875

1364

Malignant neoplasm

824

1390

3.51

199.92

3.7

2.3

218.37

233.25

e6/l

0.71

687

1153

Malignant neoplasm

823

1389

3.51

199.52

3.7

2.3

219.37

233.21

e6/l

0.64

686

1151

Malignant neoplasm, including Hilmo

832

1414

3.46

197.66

3.7

2.3

218.66

232.81

e6/l

0.68

696

1175

Asthma

633

745

4.42

195.78

2.1

2.7

239.21

248.75

e6/l

0.31

519

616

Caries of dentine

345

551

6.18

195.69

3.0

2.5

205.09

254.87

e6/l

3.06

288

470

Asthma, excluding more controls

623

721

4.48

194.96

2.1

2.7

239.94

250.13

e6/l

0.33

510

595

Bacterial Sepsis

523

1000

4.39

192.55

2.6

2.5

204.81

243.35

e6/l

2.89

442

865

Malignant neoplasm, wide definition

822

1424

3.39

189.72

3.7

2.3

217.91

234.23

e6/l

0.81

687

1182

Follicular lymphoma, hilmo

147

20.64

189.48

3.2

2.3

255.44

213.33

e6/l

0.72

124

Asthma (mode)

614

757

4.30

185.45

2.1

2.7

239.71

250.88

e6/l

0.37

503

626

Azathioprine

263

352

7.71

185.32

2.5

2.9

146.59

234.98

e6/l

7.80

216

299

Used for control exclusion in common control thyroid runs

947

1543

3.12

182.77

2.7

209.85

245.34

e6/l

4.10

800

1258

L04AD Calcineurin inhibitors

265

366

7.61

182.40

4.2

2.9

189.28

217.67

e6/l

0.52

215

294

COPD/asthma related infections

827

1237

3.38

179.25

2.7

2.5

220.95

239.10

e6/l

1.05

694

1029

COPD/asthma/ILD related infections

827

1237

3.38

179.25

2.7

2.5

220.95

239.10

e6/l

1.05

694

1029

Any reimbursement code in KELA

511

515

5.02

178.51

2.9

2.1

207.91

252.57

e6/l

3.87

406

417

Viral infections characterized by skin and mucous membrane lesions

538

1427

3.83

174.79

2.8

212.41

231.42

e6/l

1.28

437

1189

Lymphoid leukaemia

167

137

13.09

170.27

4.9

2.4

263.01

234.25

e6/l

0.29

139

116

Medical observation and evaluation for suspected diseases and conditions

542

627

4.46

168.63

3.3

2.2

222.17

239.26

e6/l

0.77

460

509

Optic neuritis

143

16.49

165.77

3.8

2.4

238.74

218.35

e6/l

0.43

119

Viral Sepsis

291

494

6.03

163.33

2.5

193.82

238.80

e6/l

2.30

242

420

Implicit bacterial Sepsis

431

844

4.44

163.27

2.5

207.40

248.88

e6/l

2.61

369

739

Implicit viral Sepsis

289

492

6.01

161.74

2.5

191.82

239.07

e6/l

2.48

240

419

Pneumonia due to other infectious organisms, not elsewhere classified

119

21.99

157.91

3.6

2.2

222.73

214.86

e6/l

0.10

112

Other and unspecified types of non-Hodgkin lymphoma, hilmo

132

17.01

155.60

3.1

2.3

215.38

232.31

e6/l

0.23

115

ILD, hospital admission 2, with pulmonary infections

159

139

11.82

154.70

2.4

2.1

213.78

252.63

e6/l

0.90

137

119

Asthma, unspecified (mode), excluding more controls

423

675

4.53

154.33

2.2

2.7

242.49

250.39

e6/l

0.22

355

561

Asthma, unspecified (mode)

427

697

4.46

153.68

2.2

2.7

244.15

248.84

e6/l

0.12

359

581

Other pulmonary diagnosis

581

753

3.90

152.94

2.8

2.7

213.35

248.82

e6/l

2.21

492

623

Asthma-related pneumonia

437

1098

4.03

152.61

2.0

2.8

251.19

222.11

e6/l

1.56

356

917

Pneumocystosis

106

28.20

152.27

3.5

2.0

218.96

208.16

e6/l

0.10

101

Pneumocystosis, including avohilmo

106

28.20

152.27

3.5

2.0

218.96

208.16

e6/l

0.10

101

General examination and investigation of persons without complaint and reported diagnosis

510

627

4.26

151.85

3.2

2.2

212.68

239.26

e6/l

1.56

441

509

Bronchitis

956

2150

2.69

151.65

2.9

2.4

228.69

230.49

e6/l

0.08

792

1819

Asthma-related pneumonia or sepsis

437

1103

4.01

151.64

2.0

2.8

251.19

222.07

e6/l

1.56

356

922

Asthma, hospital admissions 3, pneumonia

437

1103

4.01

151.64

2.0

2.8

251.19

222.07

e6/l

1.56

356

922

Implicit bacterial Sepsis, including avohilmo

453

940

4.06

151.64

2.4

2.5

208.54

246.79

e6/l

2.44

385

818

Acute sinusitis

552

1465

3.47

151.39

3.0

2.5

226.20

229.34

e6/l

0.11

445

1245

Excluding asthma or asthma-COPD overlap

578

753

3.88

151.16

2.7

215.85

248.82

e6/l

1.94

490

623

Systemic connective tissue disorders

404

972

4.23

150.55

2.4

2.6

188.55

232.51

e6/l

3.61

357

821

COPD differential diagnosis

578

757

3.86

150.18

2.8

2.7

217.47

250.88

e6/l

1.89

489

626

ILD differential diagnosis

578

757

3.86

150.16

2.8

2.7

217.47

250.88

e6/l

1.89

489

626

Asthma, hospital admission 2, infections

630

1981

3.14

149.69

2.0

2.9

246.22

221.54

e6/l

1.75

511

1651

Asthma-related infections

630

1981

3.14

149.69

2.0

2.9

246.22

221.54

e6/l

1.75

511

1651

Other special examinations and investigations of persons without complaint or reported diagnosis

515

627

4.20

149.03

2.8

2.2

221.80

239.26

e6/l

0.74

433

509

Any event in cancer register

808

1622

2.93

148.64

3.6

2.3

220.94

230.35

e6/l

0.39

670

1351

Disorders of optic nerve and visual pathways

208

279

7.79

146.78

3.5

2.5

237.47

214.15

e6/l

0.83

172

226

Protozoal diseases

119

18.86

146.40

3.4

2.4

214.66

223.13

e6/l

0.10

112

Aplastic and other anaemias

469

1154

3.77

145.76

2.9

2.5

186.56

246.86

e6/l

7.98

396

991

Bronchiectasis

160

156

10.72

144.94

1.9

265.24

211.85

e6/l

1.86

125

133

905

1674

2.76

142.83

2.6

2.4

232.85

230.42

e6/l

0.10

760

1417

Protozoal diseases, including avohilmo

119

17.51

141.35

3.4

2.3

214.66

216.94

e6/l

0.03

112

Implicit viral Sepsis, including avohilmo

343

769

4.52

139.55

2.4

2.5

191.03

239.53

e6/l

3.54

282

663

Cytomegalovirus infection, IBD co-morbidity

109

20.58

138.74

5.2

2.4

199.36

200.16

e6/l

0.01

Cytomegaloviral disease

109

20.12

137.58

5.2

2.3

199.36

202.13

e6/l

0.03

Failure and rejection of transplanted organs and tissues

25.96

134.82

9.8

2.5

205.40

190.24

e6/l

0.22

Other disorders of white blood cells

137

119

12.20

134.47

3.5

2.5

206.89

207.37

e6/l

0.01

112

108

Cytomegaloviral disease, including avohilmo

109

19.14

134.44

5.2

2.2

199.36

197.80

e6/l

0.02

Oxycodone

395

841

4.07

133.83

2.6

221.79

245.31

e6/l

1.11

349

731

Purpura and other haemorrhagic conditions

230

380

6.25

133.10

3.7

2.9

200.15

215.17

e6/l

0.37

177

323

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

172

110

11.26

133.00

2.3

2.7

211.56

254.55

e6/l

0.96

148

Acute upper respiratory infections of multiple and unspecified sites

695

1774

2.88

132.73

3.0

2.5

230.03

229.90

e6/l

0.00

571

1502

Persons encountering health services for specific procedures and health care

939

2203

2.53

132.38

2.6

2.7

209.94

239.78

e6/l

3.53

785

1828

ILD, hospital admissions 3, with pneumonia sepsis

143

135

10.97

132.24

2.4

2.1

212.22

257.43

e6/l

0.98

125

112

Chronic sinusitis

441

1236

3.61

131.97

2.3

2.7

226.49

227.18

e6/l

0.02

346

1050

Undetermined asthma

166

192

8.83

131.68

1.9

2.5

268.75

253.64

e6/l

0.27

137

153

Undetermined asthma, excluding more controls

166

196

8.65

129.54

1.9

2.5

268.75

257.05

e6/l

0.20

137

155

Headache

527

1240

3.31

129.08

2.5

217.62

244.18

e6/l

1.95

447

1034

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

827

2540

2.56

127.70

2.7

2.6

216.28

232.22

e6/l

0.93

676

2131

Examination and observation for other reasons

441

626

4.01

126.54

2.6

2.2

232.23

239.29

e6/l

0.22

351

508

Symptoms and signs involving the skin and subcutaneous tissue

669

2303

2.77

126.48

2.8

2.6

225.41

231.80

e6/l

0.32

560

1943

Zoster [herpes zoster]

245

456

5.50

124.83

3.1

2.6

208.27

224.23

e6/l

0.55

204

395

Implicit fungal Sepsis

109

15.72

123.89

2.6

2.1

197.46

220.00

e6/l

0.36

Use of interferon beta-1a

20.56

122.81

4.2

2.5

251.21

196.15

e6/l

1.33

Other anaemias

411

1071

3.64

122.27

2.9

2.4

192.91

248.21

e6/l

6.03

342

922

Fungal Sepsis

114

14.10

122.07

2.5

2.2

190.85

226.09

e6/l

0.71

Other and unspecified anaemias

408

1063

3.65

122.04

3.0

2.4

192.88

248.15

e6/l

5.96

339

917

Other/unspecified cytomegaloviral diseases

20.11

121.86

5.6

2.2

200.73

227.60

e6/l

0.38

497

1577

3.17

120.58

1.9

3.0

245.53

224.55

e6/l

1.10

398

1293

Neoplasms

666

1194

2.95

119.42

3.4

2.4

200.98

228.16

e6/l

2.56

524

976

Acute upper respiratory infections

834

1987

2.53

118.16

2.7

2.4

232.82

230.63

e6/l

0.09

685

1688

Other and unspecified disorders of white blood cells

110

14.16

117.85

4.0

2.6

204.87

216.20

e6/l

0.17

Implicit fungal Sepsis, including avohilmo

136

141

10.04

117.83

2.3

2.4

204.36

216.08

e6/l

0.23

110

124

Asthma and opportunity respiratory infection

114

13.15

117.21

1.9

2.2

273.65

193.47

e6/l

2.92

All influenza

290

656

4.49

117.13

3.2

2.8

225.31

229.01

e6/l

0.09

246

534

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

102

15.86

115.60

6.0

2.4

221.97

203.11

e6/l

0.28

Other disorders involving the immune mechanism, not elsewhere classified

104

14.82

113.75

5.9

2.5

225.25

211.88

e6/l

0.19

Coagulation defects, purpura and other haemorrhagic conditions

275

612

4.60

113.72

3.4

2.7

201.58

223.45

e6/l

0.75

212

510

Other immunodeficiencies

28.25

109.61

2.6

1.8

215.07

192.87

e6/l

0.27

Covid-19 confirmed case

383

1123

3.45

107.11

2.5

2.6

212.82

238.35

e6/l

1.58

314

948

Other respiratory diseases principally affecting the interstitium

212

398

5.44

107.02

2.2

2.3

213.31

234.95

e6/l

0.60

183

345

Other acute lower respiratory infections

520

1743

2.87

105.46

2.6

2.8

216.73

232.47

e6/l

0.83

441

1428

Mature T/NK-cell lymphomas, hilmo

26.91

104.50

3.5

2.0

215.80

202.04

e6/l

0.14

Provisional assignment of new diseases of uncertain etiology

500

1752

2.86

101.61

2.6

210.93

236.43

e6/l

2.00

406

1469

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

827

2240

2.35

101.53

3.6

2.3

212.49

233.69

e6/l

1.75

694

1855

Codes for special purposes

500

1757

2.85

101.06

2.6

210.93

236.69

e6/l

2.04

406

1471

Common variable immunodeficiency

41.77

100.91

2.7

1.3

185.22

194.63

e6/l

0.08

Implicit Sepsis

602

1679

2.66

99.69

2.3

2.6

201.92

248.43

e6/l

4.80

511

1430

Other medical care

422

1125

3.18

99.18

2.5

2.7

205.77

245.14

e6/l

2.93

350

961

Other interstitial pulmonary diseases

185

333

5.68

97.85

2.3

216.85

238.23

e6/l

0.51

160

289

Mycoses

318

880

3.67

97.58

2.7

216.37

231.87

e6/l

0.64

260

747

Interstitial lung disease

185

335

5.65

97.23

2.3

216.85

238.65

e6/l

0.52

160

291

Interstitial lung disease endpoints

185

335

5.65

97.23

2.3

216.85

238.65

e6/l

0.52

160

291

Asthma (diagnoses ohter than nonallergic)

738

2548

2.36

96.91

2.0

2.8

247.82

221.18

e6/l

2.28

600

2143

ILD, hospital admissions

184

333

5.65

96.77

2.3

216.39

237.27

e6/l

0.49

159

290

Malaise and fatigue

374

891

3.33

93.25

2.2

2.5

202.15

251.18

e6/l

3.59

312

749

Abnormalities of breathing

714

1683

2.44

92.88

2.3

2.8

223.10

230.65

e6/l

0.39

601

1376

Thrombocytopenia, unspecified

131

175

7.77

92.75

4.2

2.4

209.40

230.55

e6/l

0.32

150

Multiple myeloma, including Hilmo

17.58

92.29

3.8

1.4

225.25

206.78

e6/l

0.19

Solid cancers

596

1327

2.65

91.95

2.9

2.2

217.29

233.70

e6/l

0.88

493

1105

Neurological diseases

675

1341

2.54

91.59

3.0

2.5

231.41

224.66

e6/l

0.27

556

1079

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

152

243

6.45

91.03

6.8

2.3

232.52

218.62

e6/l

0.27

135

216

Cough

380

1137

3.15

90.52

2.9

2.8

232.75

236.04

e6/l

0.08

317

921

Dermatitis

535

2034

2.59

89.99

2.6

2.7

228.56

230.44

e6/l

0.06

438

1716

Zoster [herpes zoster], including avohilmo

431

1451

2.89

89.22

2.8

2.6

208.99

237.07

e6/l

2.24

364

1248

Solid cancers, including Hilmo

606

1386

2.56

87.57

2.9

2.3

216.17

233.76

e6/l

1.00

504

1152

Other and unspecified dermatitis

467

1726

2.73

87.42

2.6

2.7

229.20

230.07

e6/l

0.03

378

1453

Other systemic involvement of connective tissue (FG)

249

617

4.02

86.64

2.3

2.7

196.64

237.35

e6/l

2.09

216

528

Allergic asthma (mode)

201

419

4.73

86.52

1.8

2.7

237.19

250.92

e6/l

0.29

158

328

Reimbursement for rheumatic diseases

484

1820

2.67

86.36

2.1

2.8

200.84

237.47

e6/l

2.71

419

1527

Oedema, not elsewhere classified

249

618

3.97

85.60

2.5

2.4

207.31

244.23

e6/l

1.56

206

536

Complications of medical and surgical care

588

2185

2.44

85.20

3.4

2.4

228.75

234.09

e6/l

0.22

512

1848

Allergic asthma (mode), excluding more controls

201

425

4.67

85.04

1.8

2.7

237.19

253.29

e6/l

0.36

158

334

Viral pneumonia

163

298

5.59

84.82

2.6

2.7

183.75

227.43

e6/l

1.80

132

228

Certain infectious and parasitic diseases, including avohilmo

472

800

2.97

84.81

3.0

2.3

219.52

244.30

e6/l

1.37

389

666

Herpesviral [herpes simplex] infections

169

321

5.40

84.46

2.5

2.7

221.70

209.15

e6/l

0.35

133

271

Other disorders of lacrimal gland

344

1101

3.16

83.77

3.2

2.6

233.60

234.26

e6/l

0.01

307

914

Dyspnoea

700

2230

2.28

83.30

2.3

2.7

230.63

231.61

e6/l

0.04

601

1866

Asthma, hospital admissions , main diagnosis only

669

2566

2.28

83.19

1.9

2.8

243.47

221.99

e6/l

1.58

549

2144

Implicit Sepsis, including avohilmo

615

1845

2.40

81.70

2.3

2.6

202.03

245.44

e6/l

4.57

519

1563

Explicit bacterial Sepsis

138

225

6.27

80.91

3.0

2.7

200.89

231.27

e6/l

0.69

114

196

Other viral diseases

346

1134

3.09

80.48

3.8

2.7

212.94

220.54

e6/l

0.24

282

903

Other viral diseases, including avohilmo

410

1466

2.80

80.28

3.5

2.7

215.17

227.61

e6/l

0.47

332

1180

Acute bronchitis

382

1307

2.90

79.51

2.6

2.8

214.43

230.17

e6/l

0.75

325

1066

Other diseases of pleura

356

1022

3.06

79.22

2.4

2.6

204.70

246.17

e6/l

3.10

304

882

ILD, hospital admissions 1, main diag only

161

310

5.31

79.19

2.2

201.01

233.14

e6/l

0.98

137

269

Sarcoidosis

160

307

5.33

79.02

2.5

2.6

202.52

235.43

e6/l

1.23

144

256

Explicit bacterial Sepsis, including avohilmo

138

231

6.11

78.79

3.0

2.7

200.89

233.28

e6/l

0.75

114

200

Other systemic involvement of connective tissue

265

750

3.58

78.67

2.3

2.5

193.93

236.23

e6/l

2.53

231

637

Visual disturbances and blindness

455

1756

2.61

78.06

2.6

234.03

228.61

e6/l

0.22

385

1467

Persons encountering health services for examination and investigation

393

627

3.16

77.96

2.8

2.2

217.47

239.26

e6/l

0.96

322

509

Other encephalitis

13.88

77.39

3.2

2.3

232.05

195.96

e6/l

0.62

Streptococcal septicaemia

112

158

7.26

75.39

3.2

2.8

205.24

215.61

e6/l

0.16

135

Dermatitis and eczema

841

2418

2.07

75.30

2.6

2.7

230.51

229.51

e6/l

0.04

700

2033

Encephalitis

12.63

75.22

3.2

2.2

231.18

182.69

e6/l

1.08

Other or unspecified immunodeficiency

45.88

74.99

2.7

1.3

189.13

168.10

e6/l

—

Candidiasis, including avohilmo

301

955

3.19

74.50

2.5

2.6

209.90

227.80

e6/l

0.84

240

805

Pain, not elsewhere classified

230

615

3.78

74.19

2.2

2.6

233.74

254.99

e6/l

0.55

191

522

SLE (Finngen)

15.42

73.70

2.7

3.8

120.90

229.24

e6/l

2.22

Enterocolitis due to Clostridium difficile

132

226

5.97

73.69

3.1

2.4

216.40

213.61

e6/l

0.04

115

199

Chorioretinal inflammation

12.95

73.33

2.4

251.15

244.04

e6/l

0.07

Intestinal infectious diseases

735

2600

2.11

73.32

2.6

220.00

230.97

e6/l

0.60

606

2177

Streptococcal septicaemia, including avohilmo

112

164

6.99

72.86

3.2

2.7

205.24

215.17

e6/l

0.15

139

Diseases of the skin and subcutaneous tissue

689

1551

2.24

71.64

2.8

2.7

220.96

235.71

e6/l

0.78

572

1312

Polyarthropathies

537

1432

2.43

71.30

2.4

2.8

219.19

234.22

e6/l

0.68

464

1202

Chronic lower respiratory diseases

889

2344

2.01

71.18

2.1

2.9

232.96

223.77

e6/l

0.54

728

1965

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

229

260

4.45

71.00

3.1

2.2

206.88

300.07

e6/l

2.57

189

207

Diseases of the respiratory system

394

668

2.97

70.92

2.6

2.5

208.00

256.23

e6/l

2.80

325

554

Disorders of lacrimal system

375

1356

2.75

70.84

3.1

2.5

234.50

234.18

e6/l

0.01

332

1128

Bacterial intestinal infections, IBD co-morbidities

187

447

4.25

70.61

3.0

2.6

224.42

223.24

e6/l

0.02

161

377

Inflammatory diseases of the central nervous system

129

226

5.88

70.49

2.7

221.72

212.24

e6/l

0.19

106

188

Renal failure

363

1101

2.83

70.38

2.6

191.74

240.98

e6/l

4.13

322

939

Diagnoses used for exclusion with ILD

238

676

3.57

70.33

2.4

2.7

212.29

230.26

e6/l

0.64

214

582

Other bacterial intestinal infections

187

449

4.23

70.20

3.0

2.7

224.58

230.53

e6/l

0.11

161

380

Visual disturbances

418

1646

2.56

69.08

2.6

2.7

238.41

229.92

e6/l

0.36

349

1380

Hodgkin lymphoma, hilmo

12.17

68.58

2.5

2.6

207.30

243.85

e6/l

0.36

Heart failure, not strict

538

1541

2.36

68.32

2.5

2.8

203.04

238.52

e6/l

2.91

470

1315

Candidiasis

176

415

4.33

67.79

2.4

2.6

212.76

221.97

e6/l

0.23

142

349

Complications of surgical and medical care, not elsewhere classified

724

2337

2.08

67.51

3.2

2.4

223.41

232.02

e6/l

0.45

627

1959

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

461

1878

2.42

67.49

3.7

2.4

229.83

234.54

e6/l

0.17

403

1586

Other necrotizing vasculopathies

140

7.28

66.61

2.5

2.2

179.48

212.54

e6/l

0.76

124

Condition for Implicit Sepsis (Organ dysfunction codes)

603

1898

2.21

66.47

2.3

2.6

204.04

244.23

e6/l

3.99

507

1604

Herpesviral [herpes simplex] infections, including avohilmo

257

802

3.25

65.49

2.4

2.8

224.75

229.67

e6/l

0.14

202

672

Opioids

670

1600

2.17

65.48

2.6

211.95

237.42

e6/l

2.04

558

1335

Diseases of the eye and adnexa

599

1321

2.29

65.16

3.0

2.6

222.97

223.80

e6/l

0.03

497

1085

Osteopathies and chondropathies

444

1674

2.44

65.15

2.8

2.7

229.01

230.11

e6/l

0.03

380

1411

Renal tubulo-interstitial diseases

648

2256

2.12

64.76

2.6

201.88

234.64

e6/l

3.63

556

1888

Diseases of oesophagus, stomach and duodenum

767

2250

2.02

64.69

2.2

2.8

213.92

237.25

e6/l

2.04

648

1881

All kidney diseases

730

2414

2.04

64.62

2.7

203.58

234.54

e6/l

3.21

619

2009

Hernia of abdominal wall, postoperative

123

221

5.58

64.43

2.2

247.04

256.12

e6/l

0.15

108

179

Multiple myeloma and malignant plasma cell neoplasms

8.86

63.97

3.7

2.3

230.25

205.71

e6/l

0.30

Symptoms and signs involving the circulatory and respiratory systems

708

1689

2.11

63.88

2.6

2.8

222.76

230.59

e6/l

0.37

604

1382

Diarrhoea and gastroenteritis of presumed infectious origin

555

2264

2.20

63.87

2.5

2.6

225.20

231.88

e6/l

0.26

451

1878

Care involving use of rehabilitation procedures

478

1850

2.34

63.54

2.5

2.7

208.37

242.77

e6/l

3.02

390

1543

Gastrointestinal diseases

421

805

2.64

61.50

2.8

2.6

195.12

254.75

e6/l

5.11

339

660

Other disorders of skin and subcutaneous tissue, not elsewhere classified

154

356

4.40

60.86

2.7

2.4

234.19

215.40

e6/l

0.47

139

300

Infections of the skin and subcutaneous tissue

485

2134

2.25

60.05

2.7

2.8

206.16

236.01

e6/l

2.44

396

1770

Unspecified acute lower respiratory infection

174

448

3.95

59.52

2.6

2.7

241.48

223.20

e6/l

0.43

142

372

Acute lymphocytic leukaemia

21.02

58.90

8.4

2.3

132.78

232.09

e6/l

1.39

Acute lymphocytic leukaemia, including Hilmo

21.02

58.90

8.4

2.3

132.78

232.09

e6/l

1.39

Acute lymphocytic leukaemia, helper endpoint

21.02

58.90

8.4

2.3

132.78

232.09

e6/l

1.39

Other necrotizing vasculopathies (FG)

105

7.94

58.82

2.6

2.2

172.82

202.60

e6/l

0.58

Acute renal failure

188

515

3.70

58.74

2.5

182.90

244.80

e6/l

3.43

172

440

Gastro-oesophageal reflux disease

503

1919

2.22

58.73

2.3

2.8

223.74

239.83

e6/l

0.84

434

1614

Other diseases of intestines

774

2217

1.95

58.57

2.5

2.8

216.06

233.27

e6/l

1.33

634

1842

Chronic kidney disease

242

746

3.15

58.40

2.6

188.82

245.43

e6/l

3.55

217

638

Asthma and allergy

123

241

5.10

58.13

1.7

2.9

234.86

257.80

e6/l

0.32

178

Tramadol

519

1393

2.25

57.66

2.3

2.6

219.30

244.42

e6/l

1.79

440

1176

Drug-induced neutropenia

164

6.21

57.35

3.8

2.3

187.89

214.65

e6/l

0.50

144

Idiopathic thrombocytopenic purpura

9.93

57.32

3.3

2.3

194.43

217.76

e6/l

0.25

Early onset COPD, excluding more controls

129

271

4.80

57.17

1.8

2.5

232.18

262.40

e6/l

0.72

108

238

Nutritional anaemias

376

1462

2.47

57.14

2.6

183.62

242.95

e6/l

6.70

323

1240

Asthma and allergy, excluding more controls

123

245

5.02

57.08

1.7

2.9

234.86

261.40

e6/l

0.40

183

Neurological diseases, wide definition

247

357

3.50

57.04

3.2

2.3

229.26

235.41

e6/l

0.14

198

255

Procreative management

341

1080

2.63

56.84

2.5

2.9

227.49

230.43

e6/l

0.08

267

878

Disturbances of skin sensation

255

861

3.00

56.84

2.7

2.6

232.72

236.44

e6/l

0.10

207

722

Polyneuropathies and other disorders of the peripheral nervous system

194

558

3.52

56.38

3.4

2.7

234.44

234.55

e6/l

0.00

164

483

All chronic kidney diseases

414

1392

2.39

56.26

2.5

2.7

192.79

235.94

e6/l

4.04

364

1160

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

615

2027

2.06

56.24

2.3

2.6

202.73

245.70

e6/l

4.59

508

1703

Systemic lupus erythematosus

9.82

55.43

2.7

2.5

120.90

228.89

e6/l

3.40

Nausea and vomiting

242

784

3.04

55.13

3.0

2.8

198.57

247.16

e6/l

2.76

195

650

Asthma/COPD (KELA code 203)

684

2337

1.96

55.00

2.1

2.9

237.76

224.07

e6/l

0.85

552

1960

Pain in joint

423

1087

2.40

54.76

2.2

2.6

220.82

233.95

e6/l

0.56

362

899

Other skin changes

182

514

3.59

54.41

2.7

2.6

227.63

226.15

e6/l

0.03

157

441

Erysipelas

327

1096

2.59

53.72

2.3

2.4

231.79

252.74

e6/l

0.81

276

953

ILD-related respiratory insufficiency

9.97

53.38

2.3

176.35

232.19

e6/l

0.81

Iron deficiency anaemia

329

1285

2.53

53.02

2.5

2.6

181.23

241.48

e6/l

6.10

281

1076

Erysipelas, including avohilmo

423

1360

2.32

52.94

2.2

2.5

226.01

253.57

e6/l

1.43

355

1155

Abnormal findings on diagnostic imaging of central nervous system

123

6.89

52.38

3.2

3.1

231.67

227.15

e6/l

0.06

101

Other specified/unspecified systemic involvement of connective tissue

114

7.13

52.24

1.9

3.0

175.69

212.32

e6/l

0.82

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

120

6.90

52.19

2.3

2.2

165.39

228.15

e6/l

1.88

103

Dialysis, with operation codes

140

340

4.20

51.99

2.8

3.0

141.32

221.38

e6/l

4.22

116

285

Chronic rhinitis, nasopharyngitis and pharyngitis

275

1015

2.74

51.93

2.0

2.9

234.44

225.61

e6/l

0.26

223

835

Malignant neoplasm of eye, brain and central nervous system

8.94

51.93

2.0

2.4

182.51

236.97

e6/l

1.13

Codeine

593

1562

2.06

51.60

2.5

219.42

238.76

e6/l

1.31

500

1306

Other bacterial intestinal infections, including avohilmo

208

661

3.18

51.53

3.1

2.6

233.50

232.85

e6/l

0.01

178

557

Symptoms and signs concerning food and fluid intake

102

193

5.36

51.05

2.5

2.4

200.28

255.02

e6/l

1.73

165

Finngen Rheumatological endpoints

663

1928

1.96

51.04

2.5

2.8

207.01

237.80

e6/l

3.19

557

1603

Non-allergic asthma (mode)

129

298

4.33

50.21

1.5

2.5

245.03

258.29

e6/l

0.19

100

234

Parasetamol

484

1106

2.22

49.82

2.7

2.6

214.64

230.55

e6/l

0.85

391

915

Other problems related to primary support group, including family circumstances

169

468

3.59

49.79

4.0

2.6

213.03

216.61

e6/l

0.06

127

373

Budesonide

128

300

4.33

49.72

2.1

2.8

150.65

243.93

e6/l

6.34

107

259

Non-allergic asthma (mode), excluding more controls

128

299

4.28

49.11

1.5

2.5

245.03

254.50

e6/l

0.13

100

235

Asthma, including avohilmo

813

2480

1.81

49.06

2.1

2.8

239.68

223.81

e6/l

1.10

662

2088

Disorders of eyelid, lacrimal system and orbit

602

2266

1.96

48.83

2.9

2.6

218.95

233.97

e6/l

0.67

534

1907

Osteoporosis

196

563

3.23

48.82

2.9

2.3

233.78

227.27

e6/l

0.13

165

480

6-mercaptopurine

8.15

48.78

4.0

2.8

103.70

228.64

e6/l

7.46

Other diseases of the respiratory system

169

489

3.50

48.71

2.3

2.8

189.78

230.14

e6/l

1.65

138

417

Other respiratory disorders and diseases

169

489

3.50

48.71

2.3

2.8

189.78

230.14

e6/l

1.65

138

417

Other diseases of upper respiratory tract

704

1939

1.90

48.42

2.6

2.7

241.15

229.16

e6/l

0.63

596

1619

Viral pneumonia (known virus, not influenza)

8.90

48.06

3.3

2.9

181.16

212.00

e6/l

0.40

L01XX Other antineoplastic agents

100

7.29

47.98

3.4

1.9

211.07

230.45

e6/l

0.23

Acquired haemolytic anaemia

10.95

47.65

3.6

1.9

155.70

220.98

e6/l

1.26

FESS (DNB20)

135

346

3.97

46.62

2.5

2.7

219.78

223.01

e6/l

0.07

112

300

Respiratory insufficiency

7.74

46.56

1.8

2.2

212.59

259.72

e6/l

0.72

Haemorrhage from respiratory passages

236

743

2.83

46.51

2.6

2.7

224.62

236.29

e6/l

0.31

196

627

Ethmoidectomy

138

361

3.89

46.30

2.5

2.8

219.93

221.67

e6/l

0.04

115

311

Cardiovascular diseases

494

1241

2.13

46.26

2.6

3.0

204.40

231.48

e6/l

1.79

397

1002

Nephropathy related operations

135

349

3.94

46.10

2.8

145.72

220.77

e6/l

3.82

111

290

Other disorders of skin and subcutaneous tissue

496

2073

2.03

45.98

2.4

2.6

233.06

232.65

e6/l

0.01

411

1765

Symptoms and signs involving the nervous and musculoskeletal systems

426

2019

2.12

45.87

2.9

2.6

237.70

229.24

e6/l

0.35

365

1685

Symptoms and signs involving the urinary system

522

1973

2.01

45.77

3.0

2.6

239.37

234.00

e6/l

0.20

454

1672

Other reaction to severe stress, and adjustment disorders

308

1278

2.43

45.64

3.4

2.7

209.17

228.87

e6/l

1.02

271

1053

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

356

1514

2.28

45.54

2.1

2.8

237.11

231.45

e6/l

0.16

301

1285

Drug-induced cataract

10.54

45.49

3.6

2.5

159.75

236.51

e6/l

1.73

Haemolytic anaemias

7.75

45.24

3.9

2.6

157.41

212.03

e6/l

1.51

Other and unspecified iron deficiency

266

1038

2.58

44.84

2.6

191.40

231.31

e6/l

2.94

226

871

Factors influencing health status and contact with health services

155

188

4.16

44.82

3.1

2.1

229.30

267.42

e6/l

0.85

135

158

Urticaria and erythema

318

1352

2.37

44.74

2.6

2.8

216.79

227.32

e6/l

0.39

251

1108

Noninfective enteritis and colitis

373

1697

2.21

44.51

2.4

2.9

194.97

234.70

e6/l

2.76

322

1389

Other functional intestinal disorders

345

1375

2.29

44.23

2.6

2.8

221.80

241.06

e6/l

0.81

283

1145

Continuous positive airway pressure

162

394

3.46

43.87

2.5

3.1

261.73

248.27

e6/l

0.26

143

315

Intestinal infectious diseases, including avohilmo, including avohilmo

764

2404

1.78

43.42

2.6

224.96

231.73

e6/l

0.32

628

2022

Malignant neoplasm of brain

9.00

43.34

2.0

2.4

164.57

239.72

e6/l

1.77

Subjective visual disturbances

212

754

2.84

43.14

2.5

2.8

246.88

223.25

e6/l

0.95

176

629

Hypothyroidism (congenital or acquired)

176

281

3.53

43.10

2.3

2.4

198.54

234.04

e6/l

1.58

137

229

Adrenocortical insufficiency

7.19

43.04

1.8

2.4

260.64

219.67

e6/l

0.54

Viral infections of the central nervous system, including avohilmo

202

4.86

42.83

2.7

2.5

226.29

218.92

e6/l

0.13

170

Molar incisor enamel hypoplasia, with caries

8.72

42.66

6.1

2.5

129.00

230.38

e6/l

2.50

Rheumatoid arthritis

228

740

2.75

42.55

2.1

2.7

221.30

239.18

e6/l

0.53

197

634

Any death

404

1315

2.16

42.44

2.5

2.6

188.18

248.81

e6/l

5.73

349

1144

Other specific joint derangements/joint disorders

529

1682

1.97

42.33

2.4

2.7

219.59

228.61

e6/l

0.41

454

1386

Stomatitis and related lesions

195

671

2.94

42.23

3.7

2.7

199.45

220.79

e6/l

0.90

157

554

Recurrent aphthous stomatitis , including avohilmo

151

447

3.43

42.16

3.9

2.6

198.27

221.05

e6/l

0.78

123

366

Seropositive rheumatoid arthritis

178

580

3.08

41.88

2.2

2.7

224.52

242.14

e6/l

0.44

155

502

Viral infections of the central nervous system

183

5.03

41.82

2.7

2.5

225.03

218.12

e6/l

0.11

156

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

677

2417

1.80

41.77

2.5

2.6

226.83

231.71

e6/l

0.21

553

2032

Symptoms and signs involving the digestive system and abdomen

652

1766

1.86

41.65

2.8

2.7

211.27

242.38

e6/l

2.68

527

1471

Malignant neoplasm of brain, including Hilmo

7.10

41.63

2.1

2.4

154.81

218.96

e6/l

1.93

Other and unspecified polyneuropathies, also in other diseases

153

461

3.36

41.49

3.1

2.6

244.87

238.85

e6/l

0.11

130

402

Hypothyroidism and >3 levothyroxin purchases

172

279

3.48

41.29

2.3

2.4

198.49

235.54

e6/l

1.67

135

227

Hypothyroidism, levothyroxine purchases

172

279

3.48

41.29

2.3

2.4

198.49

235.54

e6/l

1.67

135

227

Special screening examination for infectious and parasitic diseases

164

358

3.36

41.03

2.3

2.4

225.79

230.59

e6/l

0.11

134

278

Gout, FINNGEN

186

628

2.97

41.01

2.9

2.4

238.23

239.46

e6/l

0.02

163

556

Methotrexate

108

258

4.24

40.98

1.9

2.8

246.09

236.17

e6/l

0.14

224

Cardiovascular diseases (excluding rheumatic etc)

498

1432

2.00

40.74

2.5

3.0

206.55

232.35

e6/l

1.71

397

1160

Mycoses, including avohilmo

630

2662

1.81

40.68

2.6

218.76

230.79

e6/l

0.72

514

2254

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

235

583

2.73

40.59

2.2

1.9

252.54

231.52

e6/l

0.62

203

503

Other malignant neoplasms of skin (=non-melanoma skin cancer)

228

561

2.77

40.49

2.3

1.9

253.66

231.81

e6/l

0.65

196

483

Pain in throat and chest

529

1616

1.95

40.47

2.5

2.8

237.05

232.91

e6/l

0.15

440

1323

Sulfasalazine

178

596

3.01

40.37

2.3

2.9

231.79

248.25

e6/l

0.39

149

519

Other viral diseases, not elsewhere classified

196

691

2.87

40.37

3.4

2.7

234.44

216.73

e6/l

0.42

160

548

Abnormal findings on examination of blood, without diagnosis

334

1360

2.24

40.35

2.5

2.7

211.59

238.57

e6/l

1.30

269

1179

Gout

186

538

2.99

40.18

2.9

2.6

238.23

244.80

e6/l

0.12

163

478

Other symptoms and signs involving the digestive system and abdomen

140

413

3.43

39.27

3.2

2.8

182.02

234.26

e6/l

3.19

122

351

Migraine

388

1443

2.10

39.07

2.4

2.7

215.79

217.02

e6/l

0.04

325

1184

Other disorders of optic [2nd] nerve and visual pathways

179

4.93

38.95

3.3

2.7

232.22

222.14

e6/l

0.17

142

Neuromuscular dysfunction of bladder

216

4.48

38.53

3.3

2.4

241.62

233.93

e6/l

0.14

186

11.24

38.43

1.6

2.6

268.91

259.88

e6/l

0.06

Disorders of other endocrine glands

345

1596

2.14

38.03

3.0

2.7

215.38

230.68

e6/l

0.68

282

1318

Low back pain

513

1831

1.90

37.73

2.5

2.6

219.62

230.03

e6/l

0.51

435

1530

Localized swelling, mass and lump of skin and subcutaneous tissue

239

966

2.50

37.71

2.9

2.6

217.19

229.11

e6/l

0.36

207

812

Follow-up examination after treatment for conditions other than malignant neoplasms

215

522

2.76

37.61

2.9

2.3

205.97

241.38

e6/l

1.67

179

426

COPD (mode)

141

320

3.46

37.59

1.9

2.4

236.88

253.36

e6/l

0.40

123

284

Other noninfective gastroenteritis and colitis

220

856

2.60

37.57

2.5

2.9

215.86

224.41

e6/l

0.20

187

691

Other soft tissue disorders, not elsewhere classified

637

2031

1.79

37.49

2.6

2.7

228.56

230.21

e6/l

0.05

535

1665

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

154

5.16

37.48

2.8

2.0

201.69

221.32

e6/l

0.31

137

Polyuria

169

577

2.96

37.13

3.4

2.5

235.70

226.13

e6/l

0.26

149

494

Codeine or tramadol medication

699

2187

1.74

37.10

2.4

2.6

222.51

232.36

e6/l

0.58

598

1847

Human immunodeficiency virus [HIV] disease

9.20

37.01

5.8

2.6

304.55

226.24

e6/l

1.19

Malignant neoplasm of skin

242

645

2.55

36.69

2.4

2.0

259.73

229.31

e6/l

1.11

208

557

Dermatitis due to substances taken internally

129

5.56

36.37

3.3

3.0

240.48

205.32

e6/l

0.46

108

Vocal cord dysfunction

109

246

3.94

36.22

2.0

3.7

254.38

268.16

e6/l

0.19

213

Disorders of sclera, cornea, iris and ciliary body

381

1900

2.02

35.96

2.7

236.02

232.29

e6/l

0.13

334

1587

Human immunodeficiency virus [HIV] disease, including avohilmo

8.86

35.95

5.8

2.6

304.55

222.81

e6/l

1.30

Other viral diseases, not elsewhere classified, including avohilmo

251

1055

2.39

35.87

3.1

2.8

234.39

226.68

e6/l

0.18

202

835

Osteoporosis with pathological fracture (FG)

107

5.99

35.58

2.3

1.9

222.30

197.07

e6/l

0.33

Convulsions, not elsewhere classified

159

534

2.96

35.06

2.4

2.7

212.50

242.51

e6/l

1.01

121

451

Other symptoms and signs involving the nervous and musculoskeletal systems

305

1415

2.17

34.93

3.2

2.7

243.39

229.09

e6/l

0.51

264

1180

Abdominal and pelvic pain

623

1766

1.78

34.79

2.9

2.7

214.49

242.38

e6/l

2.23

516

1471

Urticaria

257

1115

2.33

34.69

2.6

2.9

224.10

225.74

e6/l

0.04

204

908

Nonsuppurative otitis media

217

748

2.54

34.52

2.9

2.6

210.16

206.26

e6/l

0.10

173

596

Dysphagia

173

625

2.79

34.27

2.0

2.6

235.36

247.29

e6/l

0.30

140

541

Pulmonary heart disease, diseases of pulmonary circulation

206

813

2.55

34.20

2.5

229.06

238.33

e6/l

0.22

185

704

Care involving dialysis

200

4.39

33.96

2.6

3.2

142.08

230.01

e6/l

2.98

169

Depression medications

178

295

3.05

33.83

3.1

2.3

220.10

229.84

e6/l

0.24

143

238

All influenza (not pneumonia)

124

373

3.36

33.80

3.3

2.7

239.05

226.87

e6/l

0.19

100

297

Sicca syndrome [Sjögren]

173

4.65

33.62

2.4

183.91

213.26

e6/l

0.45

147

Malignant neoplasm of skin, including Hilmo

250

700

2.40

33.43

2.4

2.0

251.46

228.65

e6/l

0.80

215

607

Anxiety disorders, excluding more controls

536

1905

1.80

33.31

2.9

2.6

217.90

231.52

e6/l

0.93

461

1603

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

114

260

3.63

33.25

2.5

1.7

224.90

227.20

e6/l

0.03

227

Persons encountering health services in other circumstances, wide

715

2193

1.68

33.10

2.6

2.7

214.14

236.02

e6/l

1.85

607

1837

Generalized skin eruption due to drugs and medicaments

6.04

32.73

3.5

3.1

237.59

212.76

e6/l

0.23

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

232

4.03

32.63

2.5

2.3

241.21

206.68

e6/l

0.63

196

Hypoplasia of dental enamel

113

6.37

32.59

5.9

3.3

117.27

196.40

e6/l

2.14

Rheumatoid arthritis, including avohilmo

248

1094

2.28

32.21

2.0

2.5

219.18

234.12

e6/l

0.48

212

935

Complications of procedures, not elsewhere classified

495

2219

1.80

32.19

2.3

2.4

222.17

234.11

e6/l

0.55

426

1868

Chronic diseases of tonsils and adenoids

503

1749

1.82

32.12

2.8

237.05

227.60

e6/l

0.37

424

1454

Idiopathic pulmonary fibrosis

144

4.95

32.11

1.7

2.1

216.88

226.74

e6/l

0.10

129

Other/unspecified rheumatoid arthritis

249

3.87

31.89

2.0

2.3

211.23

222.32

e6/l

0.19

215

Persons encountering health services for other counselling and medical advice, not elsewhere classified

688

2191

1.67

31.60

2.7

217.04

235.95

e6/l

1.56

571

1836

Other disorders of urethra and urinary system

443

1652

1.87

31.60

2.5

205.96

232.83

e6/l

1.90

376

1414

Acute generalized exanthematous pustulosis

113

5.55

31.58

3.7

3.2

233.15

216.09

e6/l

0.16

100

Cellulitis

182

706

2.60

31.44

2.7

190.77

224.88

e6/l

1.32

154

594

Lower back pain or/and sciatica

665

2484

1.67

31.32

2.4

2.6

224.08

231.01

e6/l

0.38

567

2100

Neurotic, stress-related and somatoform disorders

586

2360

1.72

31.23

2.9

2.7

218.69

229.17

e6/l

0.64

502

1966

Other disorders of fluid, electrolyte and acid-base balance

209

813

2.44

31.16

2.0

2.6

194.13

243.74

e6/l

3.13

180

711

COPD, hospital admissions 3, with asthma pneumonia sepsis

168

534

2.72

30.59

1.8

2.5

248.16

236.45

e6/l

0.28

149

471

Drug-induced adrenocortical insufficiency

8.31

30.53

1.9

2.3

264.11

226.15

e6/l

0.30

Other arthritis (FG)

211

889

2.39

30.51

2.1

2.9

219.30

243.47

e6/l

0.78

185

755

Pain (limb, back, neck, head abdominally)

436

1152

1.90

30.23

2.8

2.6

214.58

235.97

e6/l

1.17

353

943

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

245

1092

2.24

30.19

3.7

2.6

214.33

226.89

e6/l

0.33

187

877

Noninfectious colitis NAS

120

381

3.19

30.04

2.9

229.92

219.34

e6/l

0.15

100

314

Anxiety disorders

587

2381

1.70

30.03

2.9

2.6

218.73

228.89

e6/l

0.62

503

1986

Chronic laryngitis and laryngotracheitis

113

346

3.31

30.02

2.0

2.8

219.03

226.29

e6/l

0.17

106

297

Other specified/unspecified arthritis

192

784

2.47

29.77

2.1

2.8

222.48

234.24

e6/l

0.28

168

656

Seropositive rheumatoid arthritis, wide

178

702

2.56

29.72

2.2

2.5

224.52

228.27

e6/l

0.07

155

607

Nerve, nerve root and plexus disorders

637

2302

1.67

29.68

2.5

2.6

221.51

237.31

e6/l

1.14

552

1941

Acute suppurative otitis media

238

991

2.26

29.67

3.1

2.7

208.67

214.28

e6/l

0.19

196

790

Pain in limb

540

1982

1.74

29.59

2.7

225.01

230.91

e6/l

0.17

452

1631

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

174

681

2.58

29.53

2.1

2.6

223.61

227.10

e6/l

0.07

152

589

DVT of lower extremities and pulmonary embolism

247

1123

2.20

29.49

2.6

2.5

226.55

237.86

e6/l

0.36

215

978

5-aminosalicylic acid

143

509

2.83

29.22

2.1

3.0

171.25

242.33

e6/l

3.37

118

430

Pulmonary embolism

184

744

2.49

29.12

2.6

2.5

222.81

241.00

e6/l

0.55

166

646

Other disorders of adrenal gland

141

4.81

29.09

1.8

2.6

256.50

219.96

e6/l

0.49

114

Other/unspecified seropositive rheumatoid arthritis

175

692

2.55

29.08

2.1

2.6

223.69

228.56

e6/l

0.10

153

599

Syncope and collapse

217

776

2.34

29.07

2.3

2.5

233.56

245.26

e6/l

0.26

181

668

Pulmonary heart disease

184

745

2.49

29.04

2.6

2.5

222.81

238.93

e6/l

0.47

166

646

Other diseases of pericardium

6.16

28.98

2.3

151.92

240.51

e6/l

1.87

Other heart diseases

343

1124

1.99

28.94

2.6

3.1

202.95

238.88

e6/l

2.18

285

917

Pneumonia derived septicemia

5.82

28.79

2.7

3.2

217.63

201.38

e6/l

0.13

Glomerular diseases

142

509

2.82

28.70

2.0

2.9

156.42

227.88

e6/l

4.32

127

425

Episodal and paroxysmal disorders

682

2119

1.64

28.60

2.6

2.8

235.10

227.61

e6/l

0.34

577

1736

Other diseases of lip and oral mucosa

292

1443

2.04

28.44

2.6

2.8

217.58

231.35

e6/l

0.51

243

1220

Obesity related asthma

237

1083

2.20

28.34

1.9

2.9

269.85

229.61

e6/l

1.55

201

931

Diplopia

106

325

3.30

28.14

2.9

2.8

202.68

217.41

e6/l

0.38

277

Nonsuppurative otitis media, including avohilmo

261

1064

2.14

28.06

2.6

2.7

219.62

213.53

e6/l

0.20

207

859

Other and unspecified urticaria

171

682

2.53

27.98

2.3

3.0

229.71

217.94

e6/l

0.28

140

558

Diseases of the musculoskeletal system and connective tissue

366

939

1.96

27.77

2.7

211.76

230.48

e6/l

0.95

291

730

Pneumococcal septicemia

5.93

27.71

2.8

3.2

220.79

198.77

e6/l

0.17

Conjunctivitis (acute, non atopic)

236

1084

2.19

27.58

2.6

2.8

237.23

228.65

e6/l

0.12

204

876

Extracorporeal dialysis

160

4.41

27.45

2.9

2.6

151.07

230.06

e6/l

1.92

140

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

352

1874

1.88

27.32

2.3

2.5

222.46

235.86

e6/l

0.56

306

1586

Malignant neoplasm, without specification of site, including Hilmo

7.99

27.27

3.1

1.7

195.47

202.60

e6/l

0.06

Diseases of middle ear and mastoid

406

1837

1.81

27.03

2.6

216.07

229.42

e6/l

0.69

336

1516

Disorders of thyroid, IBD co-morbidities

101

196

3.55

27.00

2.5

2.3

232.89

232.55

e6/l

0.01

159

Other heart diseases, wide

595

2185

1.65

26.98

2.6

2.8

212.49

236.61

e6/l

1.68

488

1816

Postprocedural disorders of nervous system

210

3.88

26.93

3.0

2.6

223.77

220.87

e6/l

0.05

173

Iridocyclitis

170

689

2.49

26.88

2.2

2.8

233.61

226.25

e6/l

0.19

152

578

Glomerular disorders in diseases classified elsewhere

293

3.36

26.42

1.9

2.9

144.84

223.56

e6/l

4.03

252

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

5.39

26.37

2.2

1.6

231.47

208.43

e6/l

0.27

Heart failure,strict

281

957

2.06

26.36

2.4

2.6

200.94

249.83

e6/l

2.90

249

824

Disorders of conjunctiva

547

2564

1.66

26.34

2.5

2.7

224.39

227.40

e6/l

0.08

450

2134

Irritable bowel syndrome

191

823

2.34

26.33

2.2

2.8

222.15

239.95

e6/l

0.61

157

686

COPD-related respiratory insufficiency

236

3.64

26.32

1.7

2.1

260.45

241.87

e6/l

0.30

209

COPD, hospital admission 2, with asthma infections

185

668

2.40

26.26

1.8

2.6

251.15

241.18

e6/l

0.24

162

586

Venous thromboembolism

309

1539

1.94

26.24

2.5

231.69

238.79

e6/l

0.20

263

1336

Dorsalgia

594

1910

1.65

26.16

2.5

2.6

225.92

229.52

e6/l

0.15

503

1586

Molar incisor enamel hypoplasia

241

3.63

26.00

4.9

3.0

144.73

200.86

e6/l

2.10

173

Mood disorders, excluding more controls

558

1976

1.66

25.86

2.8

2.6

224.61

232.22

e6/l

0.40

469

1667

Diseases of the ear and mastoid process

687

2169

1.59

25.73

2.5

2.7

239.35

221.97

e6/l

0.79

569

1814

Suppurative and unspecified otitis media

283

1261

2.00

25.71

3.0

2.7

210.92

220.40

e6/l

0.35

236

1014

Other (seronegative) rheumatoid arthritis, wide

131

478

2.77

25.64

2.0

2.6

220.88

226.86

e6/l

0.10

112

412

Other and unspecified drugs and medicaments

222

3.71

25.63

2.4

2.6

249.50

212.37

e6/l

0.63

189

Viral warts

295

3.30

25.47

2.5

2.8

193.67

208.51

e6/l

0.32

247

Functional dyspepsia

178

757

2.37

25.31

2.2

2.7

232.33

232.98

e6/l

0.01

150

643

Vasomotor and allergic rhinitis

257

1236

2.04

25.26

2.1

2.8

228.04

217.66

e6/l

0.38

212

1003

Metabolic disorders

579

2129

1.64

25.25

2.5

2.8

217.49

236.41

e6/l

1.16

473

1793

Other complications of surgical and medical care, not elsewhere classified

253

3.49

25.17

2.4

197.00

212.17

e6/l

0.26

211

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

120

4.73

25.02

2.1

1.4

256.10

227.28

e6/l

0.30

108

Disorders of ocular muscles, binocular movement, accommodation and refraction

344

1859

1.84

25.02

3.1

2.8

213.36

231.20

e6/l

0.80

282

1518

Other intervertebral disc disorders

472

1637

1.72

25.00

2.5

2.6

232.63

238.06

e6/l

0.22

418

1377

Malignant neoplasm of other connective and soft tissue

8.67

24.99

2.0

1.5

213.68

259.61

e6/l

0.40

Abnormal findings on diagnostic imaging of other body structures

103

334

3.12

24.95

2.6

2.5

190.57

235.82

e6/l

1.72

276

Myeloproliferative diseases

172

4.07

24.94

4.0

2.1

210.46

222.91

e6/l

0.18

154

Basal cell carcinoma, including Hilmo

195

566

2.34

24.92

2.3

1.9

245.62

233.45

e6/l

0.30

167

488

Chronic ulcer of skin, not elsewhere classified

143

4.41

24.81

2.0

230.21

220.87

e6/l

0.12

126

Childhood asthma (age<16)

232

3.33

24.81

2.3

2.9

196.34

240.35

e6/l

1.33

168

Acute tubulo-interstitial nephritis

372

1743

1.81

24.78

2.6

209.44

238.62

e6/l

1.89

315

1457

Hypoparathyroidism

5.85

24.70

1.7

2.2

235.97

200.54

e6/l

0.50

Other neurological diseases

415

1839

1.76

24.69

2.6

238.53

235.19

e6/l

0.11

358

1559

Exclusions for E4_PCOS_BROAD

161

663

2.45

24.63

2.5

3.0

209.06

209.37

e6/l

0.01

121

539

Lung cancer and mesothelioma

187

3.70

24.61

2.5

2.1

229.81

254.96

e6/l

0.29

162

Acute pharyngitis

130

478

2.72

24.56

2.4

2.7

236.88

227.75

e6/l

0.20

106

374

Otitis media, unspecified

120

391

2.86

24.50

3.0

2.7

216.98

204.01

e6/l

0.27

301

Meningitis

113

4.88

24.38

1.8

2.5

202.54

214.44

e6/l

0.15

Childhood asthma (age<16), excluding more controls

231

3.31

24.33

2.3

2.9

197.36

241.24

e6/l

1.31

168

Other disorders of eye and adnexa

123

449

2.77

24.12

3.1

2.6

261.94

204.02

e6/l

2.37

105

361

Disorders of lens

374

1277

1.82

24.10

2.6

218.29

231.63

e6/l

0.52

320

1111

Lack of expected normal physiological development

5.78

24.04

4.4

2.1

166.21

235.22

e6/l

1.37

Later onset COPD, excluding more controls

171

3.68

23.94

1.9

2.1

273.89

258.63

e6/l

0.21

149

Diseases of the myoneural junction and muscle

302

3.18

23.84

2.7

2.9

225.56

215.90

e6/l

0.17

258

Depression

583

2443

1.60

23.78

2.8

2.6

220.18

229.75

e6/l

0.57

483

2061

Persons encountering health services in other circumstances

269

1364

1.96

23.67

2.3

2.7

216.58

236.18

e6/l

0.76

243

1130

Malignant neoplasm of other connective and soft tissue, including Hilmo

6.41

23.59

1.8

1.5

233.00

226.72

e6/l

0.05

Malignant neoplasm of respiratory system and intrathoracic organs

233

3.29

23.40

2.3

1.7

201.64

232.99

e6/l

0.78

202

Other diseases of urinary system

596

2100

1.60

23.33

2.9

2.6

217.14

230.50

e6/l

0.76

499

1778

Pleural effusion

311

3.11

23.31

2.6

2.4

198.76

242.24

e6/l

1.30

276

Conjunctivitis

495

2438

1.64

23.07

2.6

2.7

223.40

224.86

e6/l

0.04

407

2021

Inflammatory bowel disease

228

1114

2.06

23.06

2.3

3.0

169.84

232.99

e6/l

5.56

196

922

Cutaneous abscess, furuncle and carbuncle

194

892

2.19

22.99

2.3

2.9

198.66

231.80

e6/l

1.55

155

748

Diaphragmatic hernia

207

978

2.13

22.86

2.3

2.5

236.26

234.68

e6/l

0.03

174

856

Secondary hypertension

189

3.75

22.85

1.8

3.2

160.49

233.22

e6/l

1.83

155

Antihypertensive medication - note that there are other indications

431

1300

1.74

22.83

2.5

2.9

191.78

225.33

e6/l

2.74

346

1051

Symptoms and signs involving speech and voice

211

1005

2.11

22.83

1.9

2.6

228.23

231.71

e6/l

0.10

175

862

Chronic gastritis

149

617

2.43

22.54

2.4

200.38

239.81

e6/l

1.81

128

541

Other and unspecified tonsillitis

226

911

2.07

22.50

2.6

2.7

210.24

236.15

e6/l

1.30

196

736

Basal cell carcinoma

182

541

2.30

22.49

2.3

1.9

246.55

229.90

e6/l

0.44

156

466

Other dorsopathies, not elsewhere classified

589

1926

1.59

22.41

2.5

2.6

227.09

228.96

e6/l

0.07

499

1599

Unspecified kidney failure

209

3.58

22.40

2.3

2.5

184.56

220.54

e6/l

0.89

180

Bleeding

484

2070

1.64

22.29

2.6

2.7

225.24

232.29

e6/l

0.25

409

1748

Mood disorders

608

2496

1.56

22.23

2.7

2.6

222.97

229.77

e6/l

0.35

503

2109

Biological medication for rheuma

151

634

2.41

22.23

1.8

3.0

207.11

217.79

e6/l

0.29

128

516

Allergic bronchopulmonary aspergillosis (ABPA)

51.57

22.20

3.5

3.0

193.89

188.17

e6/l

—

Viral encephalitis, not elsewhere classified/unspecified

7.28

22.19

1.6

2.0

241.29

193.76

e6/l

0.55

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

7.28

22.19

1.6

2.0

241.29

193.76

e6/l

0.55

Hypoplasia of dental enamel , including avohilmo

236

3.42

22.05

5.2

3.0

145.62

200.64

e6/l

1.90

168

Mood [affective] disorders

605

2495

1.56

21.87

2.7

2.6

223.48

229.39

e6/l

0.30

500

2108

Abnormality of white blood cells, not elsewhere classified

9.38

21.83

4.9

2.0

256.63

157.13

e6/l

0.70

Chronic iridocyclitis

108

4.72

21.77

2.3

232.24

223.11

e6/l

0.11

Suggestive for eosinophilic asthma

224

3.44

21.60

1.9

2.7

273.74

224.70

e6/l

1.23

199

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

276

902

1.94

21.51

2.8

3.0

221.98

243.27

e6/l

0.66

232

755

Other infectious diseases

173

3.81

21.51

3.2

2.3

204.69

230.18

e6/l

0.42

150

Eosinophilia

8.18

21.44

1.8

2.2

209.27

170.81

e6/l

0.51

Disorders of mineral metabolism

206

3.54

21.42

2.8

2.9

213.85

223.27

e6/l

0.12

177

Other and unspecified diseases of blood and blood-forming organs

6.92

21.33

2.1

2.3

299.82

201.57

e6/l

0.61

Other headache syndromes

257

1342

1.92

21.27

2.4

2.7

234.76

225.85

e6/l

0.25

212

1118

Viral meningitis, including avohilmo

4.86

21.12

2.9

2.4

219.08

226.34

e6/l

0.09

Malignant neoplasm of head and neck, including Hilmo

127

4.29

21.07

2.4

1.9

218.79

227.12

e6/l

0.11

112

Soft tissue disorders

620

2053

1.55

21.04

2.7

220.31

229.92

e6/l

0.51

523

1681

Other joint disorders

532

1736

1.60

20.84

2.6

2.8

215.24

228.90

e6/l

0.80

455

1428

Viral meningitis

5.01

20.47

2.9

2.4

221.18

221.75

e6/l

0.01

Myalgia

163

733

2.24

20.46

2.2

2.8

246.32

231.20

e6/l

0.42

142

613

Ulcerative colitis, NAS

114

438

2.63

20.30

2.3

2.7

165.71

224.25

e6/l

2.18

360

Viral pneumonia (unknown virus, not influenza)

190

3.58

20.25

2.6

2.4

193.52

212.38

e6/l

0.33

161

Malignant neoplasm of mesothelium and soft tissue

6.29

20.23

1.9

1.4

208.33

230.04

e6/l

0.20

Hypothyroidism, strict autoimmune

329

1212

1.79

20.23

2.4

2.5

204.86

248.39

e6/l

3.36

278

1014

Hypokalaemia

296

3.00

20.11

2.0

2.7

210.26

230.42

e6/l

0.45

255

Migraine without aura

159

713

2.25

20.11

2.4

2.9

193.42

217.99

e6/l

0.92

123

572

Crohn disease

108

408

2.68

19.91

2.2

2.8

155.00

221.50

e6/l

3.98

331

COPD

223

915

1.99

19.81

1.8

2.7

248.24

234.34

e6/l

0.39

194

805

Somatoform disorder

120

479

2.53

19.76

1.9

2.9

215.97

226.19

e6/l

0.26

402

Anterior Iridocyclitis

141

607

2.34

19.66

2.2

2.7

230.55

229.33

e6/l

0.03

126

505

Collagenous colitis

234

3.25

19.51

2.1

2.5

191.80

218.90

e6/l

0.70

199

Benign neoplasms

583

2066

1.54

19.48

2.4

2.7

222.58

229.14

e6/l

0.31

474

1735

Dermatopolymyositis

8.67

19.39

2.2

2.0

185.40

231.22

e6/l

0.43

Ocular pain

240

3.21

19.39

3.4

2.9

245.68

197.39

e6/l

1.60

192

Other chronic obstructive pulmonary disease

214

880

2.00

19.36

1.8

2.6

252.26

229.71

e6/l

0.73

187

776

Other/unspecified dorsalgia

220

1116

1.96

19.34

2.6

2.7

220.08

233.40

e6/l

0.45

190

933

Weight loss

288

2.99

19.23

2.5

2.7

201.49

211.90

e6/l

0.21

241

Migraine with aura

174

824

2.12

19.19

2.2

2.7

221.47

219.65

e6/l

0.04

149

669

Arthropathies

544

1763

1.56

19.14

2.6

2.8

214.41

228.23

e6/l

0.84

458

1442

Other metabolic disorders

106

405

2.64

19.12

3.5

2.8

219.95

226.97

e6/l

0.10

341

Abnormal weight loss

258

3.10

19.06

1.9

2.6

204.52

217.71

e6/l

0.26

216

Speech and linguistic disorders, excluding more controls

285

2.94

18.98

3.8

2.8

181.20

217.56

e6/l

1.07

209

Diseases of the digestive system

268

1466

1.82

18.97

2.6

2.7

213.45

232.83

e6/l

0.66

238

1234

Diseases of liver

216

1112

1.95

18.95

2.1

2.7

225.29

234.25

e6/l

0.21

179

951

Atopic dermatitis

378

1812

1.67

18.87

2.4

2.8

209.28

223.90

e6/l

0.66

308

1494

Disorders of calcium metabolism

148

3.84

18.76

2.6

191.11

211.10

e6/l

0.33

128

Sciatica+with lumbago

293

1466

1.78

18.72

2.2

2.6

226.85

236.90

e6/l

0.39

252

1242

Pericarditis

5.66

18.72

2.0

3.4

181.10

241.91

e6/l

0.93

Osteonecrosis

131

4.03

18.62

3.3

2.2

230.62

197.13

e6/l

0.42

116

Pneumonia due to Streptococcus pneumoniae

5.09

18.59

2.9

2.6

224.06

232.06

e6/l

0.09

Epilepsy

206

1051

1.97

18.39

2.3

2.9

205.63

223.08

e6/l

0.63

167

861

Lumbar disc prolapse

353

1553

1.69

18.31

2.6

236.26

239.76

e6/l

0.11

318

1315

Use of hypnotics and sedatives

602

2296

1.50

18.18

2.6

226.41

234.39

e6/l

0.38

492

1952

Hypertensive diseases (excluding secondary)

317

1052

1.76

18.09

2.0

3.0

211.19

241.48

e6/l

1.41

258

866

Constipation

518

2289

1.54

18.00

2.3

2.8

219.24

233.24

e6/l

0.74

422

1939

Dorsopathies

589

1977

1.51

17.91

2.6

2.7

229.87

228.28

e6/l

0.06

497

1632

107

425

2.54

17.85

2.7

207.45

219.71

e6/l

0.27

351

Postprocedural endocrine and metabolic disorders, not elsewhere classified

362

2.68

17.81

3.3

2.7

217.25

224.11

e6/l

0.09

309

197

898

1.98

17.76

2.4

2.3

241.22

242.60

e6/l

0.03

172

790

Other symptoms and signs involving the circulatory and respiratory systems

154

3.68

17.73

2.1

2.6

233.27

205.10

e6/l

0.41

122

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

405

2310

1.60

17.70

2.6

2.7

232.92

221.49

e6/l

0.30

337

1915

Voice disturbances

171

832

2.07

17.64

1.9

2.7

237.75

229.09

e6/l

0.25

140

709

Acute and subacute iridocyclitis

129

561

2.32

17.63

2.1

2.8

221.82

225.32

e6/l

0.08

116

468

Benign neoplasm: Colon

278

1485

1.76

17.53

2.4

2.5

241.01

234.87

e6/l

0.17

243

1300

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

5.03

17.40

3.2

2.1

264.23

231.88

e6/l

0.36

Other disorders of bone

138

621

2.24

17.40

2.9

2.8

228.56

222.10

e6/l

0.15

122

519

Other diseases of intestine

372

2.63

17.39

2.3

2.8

218.85

251.54

e6/l

0.81

323

Congenital malformations, deformations and chromosomal abnormalities

375

2198

1.62

17.38

2.6

2.7

229.15

222.02

e6/l

0.16

312

1817

Senile cataract

309

1081

1.74

17.31

2.5

2.7

218.51

233.01

e6/l

0.51

270

956

Malignant neoplasm of bronchus and lung, including Hilmo

226

2.97

17.29

2.5

1.7

225.62

233.00

e6/l

0.07

198

Missing teeth due to accident, extraction or parodontitis

334

1790

1.67

17.26

2.8

2.5

213.23

236.37

e6/l

1.38

286

1548

Pruritus

284

2.88

17.25

2.6

2.5

249.47

215.44

e6/l

0.67

234

Personal history of malignant neoplasm

201

3.27

17.20

2.5

2.4

169.81

218.00

e6/l

1.67

162

Other specified and unspecified retinal disorders

5.10

17.20

2.9

2.5

207.24

222.67

e6/l

0.17

Iron deficiency anaemia secondary to blood loss (chronic)

386

2.58

17.17

2.0

2.5

157.86

230.97

e6/l

3.03

325

Cerebrovascular diseases (FINNGEN)

181

622

2.05

17.04

2.4

3.1

243.72

238.50

e6/l

0.09

152

528

Rheumatism, unspecified

308

2.78

17.03

1.8

2.7

208.91

216.83

e6/l

0.19

266

Other infectious diseases, including avohilmo

223

3.13

16.98

3.2

2.4

204.13

230.49

e6/l

0.48

189

Tonsillectomy and adenotomy

389

1678

1.62

16.98

2.7

2.8

234.76

217.85

e6/l

0.84

321

1344

Etanercept

198

3.28

16.96

1.8

3.1

216.14

212.62

e6/l

0.05

164

Heart failure, strict

288

1145

1.75

16.94

2.3

2.6

205.08

248.09

e6/l

2.41

256

993

Heart failure and antihypertensive medication

148

433

2.23

16.94

2.5

2.8

190.19

237.54

e6/l

1.42

131

368

Misadventures to patients during surgical and medical care

355

2.64

16.85

2.4

2.3

197.33

218.75

e6/l

0.50

298

Abnormal results of function studies

230

3.08

16.76

2.3

3.0

203.81

226.07

e6/l

0.43

190

Seronegative rheumatoid arthritis

246

2.99

16.70

2.2

2.9

218.94

221.00

e6/l

0.02

218

Symptoms and signs involving cognition, perception, emotional state and behaviour

551

2474

1.49

16.64

2.3

2.7

225.27

231.05

e6/l

0.28

463

2091

Abnormalities of heart beat

183

904

1.97

16.51

2.3

2.7

211.89

239.32

e6/l

0.95

152

749

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

173

856

2.01

16.44

2.4

2.7

198.70

232.05

e6/l

1.68

143

709

Mental and behavioural disorders due to tobacco

233

3.04

16.40

2.6

2.8

239.83

219.11

e6/l

0.23

201

All-cause Heart Failure

282

1128

1.74

16.32

2.4

2.5

207.05

248.88

e6/l

2.25

251

977

Benign neoplasm of colon, rectum, anus and anal canal

322

1640

1.66

16.28

2.4

2.5

235.06

234.02

e6/l

0.03

281

1438

Smoking dependency

235

3.02

16.17

2.6

2.8

239.83

220.21

e6/l

0.22

204

Need for other prophylactic measures

170

3.41

16.04

3.5

3.1

206.57

216.38

e6/l

0.10

145

Systemic sclerosis (FG)

6.29

16.00

1.6

2.7

199.10

192.68

e6/l

0.04

Tumor necrosis factor alpha inhibitors

127

573

2.24

15.98

1.9

2.9

209.17

211.79

e6/l

0.05

107

475

Skin changes due to chronic exposure to nonionizing radiation

180

832

1.97

15.96

2.5

2.3

238.89

244.80

e6/l

0.12

158

736

Suppurative and necrotic conditions of lower respiratory tract

128

3.81

15.94

1.7

2.7

248.08

234.31

e6/l

0.09

113

Fentanyl

165

3.41

15.93

2.6

200.24

221.74

e6/l

0.32

135

Kidney transplant status

176

3.36

15.91

2.1

3.3

117.72

210.52

e6/l

2.52

144

Any mental disorder

601

2054

1.47

15.91

2.9

2.6

214.93

232.37

e6/l

1.29

497

1718

Allergic rhinitis

227

1243

1.81

15.87

2.2

3.0

223.14

223.71

e6/l

0.01

184

987

Persons encountering health services in circumstances related to reproduction

371

1548

1.61

15.86

2.9

3.0

216.90

226.53

e6/l

0.37

303

1278

Deviated nasal septum

178

913

1.96

15.82

2.2

2.8

237.71

240.80

e6/l

0.06

156

790

Other diseases of blood and blood-forming organs

148

3.56

15.70

2.2

2.7

262.07

225.13

e6/l

0.28

132

Fissure and fistula of anal and rectal regions

143

681

2.11

15.67

2.5

2.8

233.02

243.68

e6/l

0.20

119

577

Hypo-osmolality and hyponatraemia

104

430

2.42

15.67

2.0

2.7

202.83

239.36

e6/l

0.99

374

Cerebral palsy and other paralytic syndromes

328

2.65

15.66

2.8

2.9

249.96

219.10

e6/l

0.40

270

Myeloproliferative diseases (CML excluded)

158

3.46

15.63

3.9

2.2

207.45

223.76

e6/l

0.20

140

Non-ischemic cardiomyopathy

165

648

2.03

15.58

2.7

2.6

205.70

249.80

e6/l

2.02

146

560

Papilloedema, unspecified

5.31

15.41

2.7

2.6

197.04

225.37

e6/l

0.30

Malignant neoplasm of head and neck

104

4.07

15.40

2.5

1.7

234.30

221.51

e6/l

0.15

Systemic sclerosis

6.01

15.32

1.6

2.4

199.10

229.29

e6/l

0.23

Keratitis

217

1202

1.81

15.28

3.0

2.7

238.69

232.48

e6/l

0.17

187

1003

Viral warts, including avohilmo

155

770

2.03

15.20

2.7

2.9

220.11

220.17

e6/l

0.00

129

633

IBD patients in KELA-register

160

804

2.00

15.19

2.1

2.9

166.79

232.32

e6/l

3.87

136

661

Hypothyroidism, drug reimbursement

169

2.99

15.07

2.5

208.39

236.83

e6/l

0.72

142

Other antidepressants

558

1940

1.47

15.02

2.5

220.19

229.88

e6/l

0.54

457

1662

Vascular disorders of the intestines

102

4.06

14.95

1.4

2.0

188.26

221.52

e6/l

0.37

Early onset COPD

129

604

2.15

14.81

1.8

2.9

232.18

241.65

e6/l

0.18

108

526

Migraine with aura and triptan purchases

123

566

2.19

14.78

2.3

2.7

206.72

225.96

e6/l

0.53

104

449

Actinic keratosis

171

803

1.94

14.75

2.4

2.3

232.12

247.01

e6/l

0.35

150

709

Postmenopausal osteoporosis with pathological fracture

4.44

14.73

2.4

1.5

245.00

197.73

e6/l

0.45

Intracranial trauma

287

1155

1.68

14.59

2.5

2.4

228.99

229.76

e6/l

0.02

232

924

Acute lymphadenitis

166

3.30

14.51

2.8

3.1

207.00

215.26

e6/l

0.12

140

Pneumothorax

156

3.37

14.50

2.3

2.4

233.26

244.27

e6/l

0.14

142

Tuberculosis, IBD comorbidity

118

3.77

14.49

1.9

2.1

259.71

220.72

e6/l

0.41

104

Atopic dermatitis, strict definition with reimbursement

207

1103

1.81

14.45

2.4

2.8

207.02

230.50

e6/l

0.97

169

881

Spondyloarthritis

407

2.40

14.45

1.9

2.4

219.68

242.02

e6/l

0.52

332

Paralytic ileus and intestinal obstruction

131

624

2.11

14.35

2.4

2.7

217.29

246.02

e6/l

0.88

117

532

Viral and other specified intestinal infections

153

753

2.00

14.34

2.8

2.9

185.70

216.17

e6/l

1.32

132

605

Other disorders of ear

509

2245

1.47

14.24

2.6

2.7

243.38

226.62

e6/l

0.82

434

1875

Other meningitis

5.85

14.23

2.2

195.33

205.95

e6/l

0.10

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

512

2210

1.47

14.22

2.6

225.13

236.36

e6/l

0.51

432

1887

Inflammatory bowel disease, strict (require KELA)

160

824

1.95

14.20

2.1

2.9

166.79

229.65

e6/l

3.63

136

676

Other disorders of nervous system

154

3.35

14.09

1.8

2.5

243.12

210.38

e6/l

0.63

136

Carrier of infectious disease

4.89

14.08

1.9

2.5

264.57

205.59

e6/l

0.55

Erythema multiforme

5.53

14.07

2.2

2.6

184.10

196.30

e6/l

0.18

Disorders of tooth development and eruption

110

395

2.28

14.03

2.7

229.16

240.87

e6/l

0.25

338

Deforming dorsopathies

165

862

1.92

14.00

2.0

2.8

228.08

221.31

e6/l

0.17

144

734

Fibromyalgia

244

2.81

13.97

1.4

2.7

230.91

222.37

e6/l

0.15

204

Non-small cell lung cancer, including Hilmo

172

3.12

13.95

2.5

1.6

221.36

236.70

e6/l

0.13

149

COPD, early/later onset

214

1010

1.78

13.95

1.8

2.6

252.26

238.83

e6/l

0.37

187

886

Spondylopathies

387

1476

1.55

13.93

2.3

2.6

230.85

237.47

e6/l

0.24

333

1247

Other general symptoms and signs

111

3.79

13.92

2.2

2.3

213.09

247.68

e6/l

0.54

Temporomandibular joint disorders, including avohilmo

278

1639

1.65

13.91

2.1

2.6

227.87

217.96

e6/l

0.41

241

1357

Systemic sclerosis, icd10

5.42

13.78

1.6

2.4

199.10

232.50

e6/l

0.27

Abnormal involuntary movements

368

2.44

13.75

2.0

2.6

228.45

212.00

e6/l

0.39

311

Endocrine, nutritional and metabolic diseases

478

1623

1.49

13.73

2.7

2.8

208.49

233.96

e6/l

1.99

382

1333

Other CVD (FINNGEN)

177

2.91

13.73

1.8

2.8

252.40

250.39

e6/l

0.01

156

Genitourinary diseases

338

1055

1.61

13.67

3.2

2.6

220.10

232.21

e6/l

0.43

280

852

Diseases of arteries, arterioles and capillaries (FINNGEN)

127

409

2.15

13.63

2.0

3.2

212.76

247.14

e6/l

0.88

109

355

Cardiac arrhythmias

364

1498

1.56

13.62

2.6

2.9

228.85

232.68

e6/l

0.11

301

1240

COPD, hospital admissions

211

1004

1.78

13.57

1.8

2.6

251.89

239.31

e6/l

0.34

186

882

Other pleural conditions

199

2.99

13.56

2.5

2.3

183.83

242.14

e6/l

1.56

175

Bronchitis, not specified as acute or chronic

194

3.02

13.53

2.6

2.8

208.27

230.17

e6/l

0.38

160

Visual field defects

189

3.05

13.51

2.0

2.5

231.56

208.55

e6/l

0.41

168

Other or unspecified ileus, impaction or obstruction

414

2.33

13.47

2.1

2.8

212.87

247.49

e6/l

0.85

357

Disorders of parathyroid gland

106

471

2.24

13.47

2.3

2.6

224.03

223.85

e6/l

0.00

408

Urinary track infection

337

1054

1.61

13.46

2.8

2.3

206.87

223.53

e6/l

0.85

271

874

Other disorders of eyelid

211

1135

1.76

13.40

2.4

2.5

211.29

241.85

e6/l

1.84

182

974

Diseases of tongue

125

3.56

13.35

2.0

2.6

186.42

236.52

e6/l

1.02

111

Diverticular disease of intestine

327

1281

1.59

13.25

2.2

2.7

233.67

247.22

e6/l

0.46

281

1102

Disorders of psychological development

116

504

2.15

13.21

3.4

2.9

183.68

208.89

e6/l

0.88

379

Diseases of salivary glands

190

1059

1.80

13.20

2.2

2.6

213.52

235.19

e6/l

0.75

153

898

Combined immunodeficiencies

11.53

13.20

4.1

2.1

184.06

208.76

e6/l

0.21

Biological medicines for asthma

4.88

13.14

1.4

2.7

221.00

215.35

e6/l

0.06

Speech and linguistic disorders

419

2.29

13.14

4.1

2.8

190.25

207.31

e6/l

0.38

308

Depression or dysthymia

362

1269

1.56

13.13

2.8

2.6

229.17

234.03

e6/l

0.18

306

1085

Ulcerative colitis

157

828

1.91

13.02

2.1

2.9

180.56

229.32

e6/l

2.26

131

687

Tuberculosis, wide, including avohilmo

132

3.44

13.02

1.9

2.2

261.26

229.84

e6/l

0.32

116

Disorders of synovium and tendon

293

1551

1.61

13.02

2.5

2.7

230.99

234.11

e6/l

0.08

256

1304

Gastric ulcer

354

2.41

12.93

2.1

2.5

202.92

241.63

e6/l

0.60

311

Concussion

246

1136

1.68

12.93

2.5

2.4

236.14

230.40

e6/l

0.14

199

909

All anxiety disorders

366

1866

1.53

12.81

2.7

223.77

225.66

e6/l

0.07

307

1543

Intestinal stricture

162

868

1.88

12.79

2.3

2.6

199.76

240.54

e6/l

1.91

144

737

Tuberculosis, wide

129

3.44

12.74

1.9

2.2

259.71

228.43

e6/l

0.30

113

Dizziness and giddiness

403

2104

1.49

12.72

2.3

2.7

237.20

230.52

e6/l

0.28

351

1791

Migraine, single triptan purchase ok & required. ICD-code if available is included

439

2022

1.47

12.71

2.6

2.7

229.51

224.36

e6/l

0.18

368

1686

Triptan medication for migraine, single purchase ok

439

2022

1.47

12.71

2.6

2.7

229.51

224.36

e6/l

0.18

368

1686

Sequelae of external causes of morbidity and mortality

149

779

1.92

12.70

2.9

2.6

210.65

228.41

e6/l

0.48

124

664

Pain associated with micturition

328

2.46

12.63

3.6

2.5

228.13

213.90

e6/l

0.31

276

Disorders of skin appendages

301

1907

1.58

12.61

2.5

2.7

230.99

227.28

e6/l

0.11

247

1585

Viral and other specified intestinal infections, including avohilmo

189

1025

1.78

12.59

2.7

2.8

197.40

219.01

e6/l

0.85

159

817

Allergic urticaria

259

2.66

12.52

2.9

3.1

209.02

214.34

e6/l

0.10

211

Retention of urine

165

716

1.87

12.49

2.3

2.5

224.21

234.36

e6/l

0.26

139

633

Other and unspecified nerve root and plexus disorders, also in other diseases

125

619

2.03

12.46

2.7

2.8

213.57

240.50

e6/l

1.00

109

531

Papulosquamous disorders

218

1286

1.70

12.44

2.2

2.7

199.24

236.77

e6/l

2.43

184

1101

Dentofacial anomalies [including malocclusion]

415

2205

1.48

12.41

2.5

2.7

220.46

225.29

e6/l

0.22

355

1825

Other keratitis

325

2.45

12.39

3.4

2.7

238.89

214.94

e6/l

0.41

265

Specific development disorders of scholastic skills

233

2.75

12.38

5.8

2.9

180.33

193.49

e6/l

0.26

172

Disorders of choroid and retina

406

1916

1.49

12.35

2.4

2.7

222.89

232.55

e6/l

0.44

351

1637

Gastroduodenal ulcer

117

565

2.07

12.35

2.0

2.5

210.19

246.30

e6/l

0.67

102

495

Faecal incontinence

162

3.11

12.34

3.0

2.4

227.29

214.40

e6/l

0.15

141

Inflammatory diseases of female pelvic organs

337

1494

1.55

12.33

2.3

2.4

205.16

223.53

e6/l

1.04

289

1240

Chronic hepatitis, not elsewhere classified

4.23

12.28

1.1

2.1

166.44

211.57

e6/l

0.49

Seropositive rheumatoid arthritis, strict definition

401

2.29

12.23

2.5

2.6

201.31

222.35

e6/l

0.50

346

Raynaud syndrome

251

2.66

12.20

1.5

2.4

185.43

213.85

e6/l

0.74

213

Ulcerative enterocolitis

4.67

12.15

2.2

2.5

149.30

218.59

e6/l

0.87

Triptan medication for migraine, min. 3 purchases

331

1610

1.54

12.06

2.3

2.7

217.72

221.37

e6/l

0.10

276

1338

Other diseases of anus and rectum

151

805

1.88

11.99

2.5

2.7

191.95

236.38

e6/l

2.43

126

687

Anxiety (asthma-related co-morbidities)

358

1806

1.51

11.95

2.7

224.94

227.78

e6/l

0.10

302

1518

Herpesviral keratitis and keratoconjunctivitis

3.86

11.93

2.9

2.3

216.11

227.66

e6/l

0.14

Adalimumab

319

2.44

11.93

2.0

3.0

207.71

209.05

e6/l

0.02

266

Ulcer of lower limb, not elsewhere classified

313

2.44

11.89

2.3

192.75

221.02

e6/l

0.68

274

COPD, hospital admissions 1, only main diagnosis

154

709

1.87

11.88

1.9

2.4

236.11

240.70

e6/l

0.09

135

623

Recurrent or chronic depression

230

951

1.68

11.88

2.8

2.7

223.38

229.19

e6/l

0.19

189

807

Other and unspecified visual disturbances

261

2.59

11.80

2.4

2.7

266.29

207.85

e6/l

1.50

220

COPD related to multimorbidity

177

838

1.79

11.79

1.8

2.5

245.69

241.53

e6/l

0.08

154

740

Hypercalcemia

3.82

11.76

2.8

2.3

173.50

217.81

e6/l

0.78

Cystitis

439

1798

1.45

11.68

2.8

2.5

229.97

233.75

e6/l

0.12

357

1528

Cervical disc disorders

180

1029

1.76

11.54

2.3

2.7

231.37

233.10

e6/l

0.04

153

882

Unspecified fall

292

1851

1.55

11.52

2.5

2.7

220.74

231.93

e6/l

0.37

247

1533

Infections with a predominantly sexual mode of transmission

189

1094

1.73

11.50

2.6

211.03

229.79

e6/l

0.71

158

895

Convalescence

3.82

11.47

2.1

2.8

217.72

208.24

e6/l

0.11

Other chronic obstructive pulmonary disease, including avohilmo

250

1272

1.62

11.45

1.8

2.7

242.50

235.62

e6/l

0.19

220

1117

Disorders of refraction and accommodation

195

1141

1.71

11.36

3.4

2.9

214.29

219.23

e6/l

0.11

153

915

Nasal polyp

103

492

2.11

11.36

2.3

2.8

253.99

242.89

e6/l

0.23

432

Other embolism and thrombosis

308

2.42

11.35

2.3

2.5

249.39

223.66

e6/l

0.39

268

Other gastritis (incl. Duodenitis)

110

540

2.05

11.27

2.1

2.7

211.54

240.15

e6/l

0.82

468

Neuralgia and neuritis, unspecified

115

3.43

11.25

1.8

2.8

212.76

210.58

e6/l

0.02

105

Atrial fibrillation and flutter

154

533

1.87

11.21

2.8

3.2

224.40

241.77

e6/l

0.35

134

461

Diseases of inner ear

266

1619

1.58

11.18

2.2

2.6

248.12

233.82

e6/l

0.51

235

1377

Malignant neoplasm of bone and articular cartilage, including Hilmo

8.23

11.15

3.7

1.8

170.89

251.42

e6/l

0.91

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

173

2.95

11.14

3.2

3.1

183.39

210.38

e6/l

0.43

124

Benign neoplasm: Colon, unspecified

124

639

1.95

11.09

2.3

2.5

224.60

240.87

e6/l

0.37

107

561

Osteomyelitis

157

3.03

11.07

2.0

2.4

218.24

223.59

e6/l

0.06

142

Other local infections of skin and subcutaneous tissue

294

2.44

11.04

4.3

3.0

213.79

218.82

e6/l

0.08

244

Fitting and adjustment of other devices

154

746

1.82

11.01

2.5

2.6

222.36

246.72

e6/l

0.72

146

648

Heart failure and bmi 25plus

170

633

1.80

10.99

2.6

2.7

196.08

247.44

e6/l

1.94

151

563

Acute laryngitis and tracheitis

375

2.25

10.99

3.5

2.7

202.13

231.60

e6/l

0.72

289

Complications of internal orthopaedic prosthetic devices, implants and grafts

105

512

2.06

10.97

1.9

2.2

231.24

231.09

e6/l

0.00

449

Nummular dermatitis

185

2.84

10.94

3.2

2.9

268.56

227.65

e6/l

0.50

160

Gout, idiopatic and unspecified

116

587

1.99

10.94

2.9

2.4

236.25

237.92

e6/l

0.02

101

523

Glomerulonephritis

284

2.45

10.88

2.1

2.9

158.95

217.93

e6/l

1.77

235

Exposure to other specified factors

459

2806

1.41

10.85

2.6

2.7

209.26

230.39

e6/l

1.60

384

2340

Diseases of arteries, arterioles and capillaries

314

1517

1.52

10.84

1.9

2.6

198.90

242.06

e6/l

3.23

261

1323

Impetigo

170

2.93

10.84

2.7

3.0

213.00

215.60

e6/l

0.03

135

Sequelae with surgical and medical care as external cause

114

576

1.99

10.82

3.1

2.6

204.54

230.21

e6/l

0.72

496

Pollen allergy

155

855

1.80

10.74

2.4

3.1

219.87

207.35

e6/l

0.37

124

662

Other anxiety disorders

275

1509

1.56

10.74

2.6

2.7

219.95

224.89

e6/l

0.17

227

1241

Rash and other nonspecific skin eruption

256

2.52

10.72

3.2

2.6

248.04

212.03

e6/l

0.70

213

Benzodiazepine use

531

2606

1.38

10.68

2.7

2.6

225.20

230.95

e6/l

0.27

456

2190

Dental operations

274

889

1.59

10.67

2.7

2.3

203.56

252.02

e6/l

3.29

230

722

Malignant neoplasm of digestive organs, including Hilmo

143

565

1.87

10.65

2.4

2.0

258.46

232.07

e6/l

0.47

127

490

Other and unspecified local infections of skin and subcutaneous tissue

281

2.44

10.64

4.5

3.0

216.09

218.97

e6/l

0.04

235

Tongue abnormality

136

3.12

10.45

2.0

2.2

186.42

211.51

e6/l

0.40

116

Drug-induced polyneuropathy

7.90

10.38

7.0

4.2

146.44

143.96

e6/l

0.01

Disorders of gallbladder, biliary tract and pancreas

503

2262

1.39

10.38

2.8

2.6

219.99

234.41

e6/l

0.74

425

1933

Other cataract

208

936

1.66

10.33

2.6

247.17

236.67

e6/l

0.27

175

814

Meningitis, viral

12.37

10.32

1.3

1.4

273.08

161.64

e6/l

1.41

Caries of enamel

531

2540

1.37

10.29

2.9

2.6

228.31

230.12

e6/l

0.05

414

2170

Congenital malformations of the respiratory system, including avohilmo

3.59

10.26

3.0

3.7

315.88

198.49

e6/l

1.10

Dermatographic urticaria

181

2.79

10.23

2.6

2.4

243.82

217.93

e6/l

0.44

148

Malignant neoplasm of bronchus and lung

200

2.56

10.22

2.1

1.7

196.30

228.10

e6/l

0.70

175

Dialysis

128

3.18

10.19

2.3

3.0

120.18

215.32

e6/l

1.83

103

Conjunctivitis (acute, non atopic), including avohilmo

542

2401

1.37

10.15

2.7

227.28

232.07

e6/l

0.14

453

2021

Hypermobility syndrome

144

3.02

10.12

1.7

2.9

206.66

212.28

e6/l

0.09

120

Other congenital malformations

376

2.20

10.12

3.9

3.1

240.08

205.35

e6/l

0.60

286

Hernia

485

2330

1.39

10.11

2.6

237.99

232.45

e6/l

0.20

417

1941

Covid-19 suspected case

134

732

1.84

10.09

2.6

2.8

201.06

223.71

e6/l

0.85

102

602

Migraine without aura and triptan purchases

115

598

1.94

10.08

2.4

2.7

184.84

229.58

e6/l

1.87

472

Lung diseases due to external agents

307

2.33

10.04

2.1

2.4

228.68

225.09

e6/l

0.04

269

Presence of other functional implants

253

1106

1.57

9.98

2.2

231.21

238.89

e6/l

0.25

222

955

Polymyalgia rheumatica

253

2.47

9.97

2.1

241.60

223.71

e6/l

0.24

221

Paralytic strabismus

162

2.87

9.91

3.0

2.6

226.10

229.39

e6/l

0.04

142

Simple and mucopurulent chronic bronchitis

3.52

9.91

2.2

2.8

256.04

214.66

e6/l

0.49

Gout, unspecified

465

2.05

9.88

2.9

2.5

235.71

236.26

e6/l

0.01

416

Dependence on enabling machines and devices, not elsewhere classified

5.05

9.82

2.7

1.9

147.31

188.27

e6/l

0.26

Focal epilepsy, strict definition

122

653

1.88

9.80

2.4

3.0

212.05

220.71

e6/l

0.18

100

537

Spirochaetal infections, other/unspecified

220

2.57

9.77

1.9

2.4

217.12

212.35

e6/l

0.08

189

Exposure to unspecified factor

559

2829

1.35

9.77

2.3

2.7

211.55

231.70

e6/l

1.70

452

2377

Other congenital malformations, including avohilmo

103

522

1.99

9.75

3.6

2.9

251.77

210.66

e6/l

0.90

405

Other inflammation of eyelid

395

2.14

9.73

3.0

2.6

182.30

231.16

e6/l

2.10

325

Gingivitis and periodontal diseases

525

1985

1.37

9.70

2.7

2.6

212.44

234.88

e6/l

1.81

432

1671

Colonic or urogenital fistula

149

851

1.76

9.69

2.5

2.6

238.08

230.74

e6/l

0.14

124

725

Non-small cell lung cancer

110

3.25

9.63

1.9

1.5

185.68

238.02

e6/l

0.91

Abnormalities of gait and mobility

320

2.27

9.59

2.8

2.5

211.98

218.05

e6/l

0.12

275

Paraplegia, diplegia of upper limbs

4.68

9.57

4.0

2.2

212.88

191.77

e6/l

0.21

Allergic contact dermatitis

378

2.16

9.57

1.7

2.8

211.94

217.66

e6/l

0.11

318

Benign neoplasm of other and ill-defined parts of digestive system

458

2.04

9.54

2.1

2.6

219.89

228.07

e6/l

0.13

402

Conductive and sensorineural hearing loss

382

1779

1.43

9.51

2.6

2.7

248.14

225.59

e6/l

1.04

338

1511

Fracture of lumbar spine and pelvis

105

539

1.95

9.50

2.2

2.5

242.29

227.89

e6/l

0.25

466

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

122

640

1.86

9.47

2.4

3.1

234.78

206.78

e6/l

0.58

500

Disorders of vestibular function (Vertigo)

223

1384

1.57

9.44

2.3

2.6

260.94

232.79

e6/l

1.16

196

1181

Congenital malformations of the respiratory system

3.52

9.42

3.1

3.8

327.54

186.46

e6/l

1.30

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

173

1038

1.67

9.42

2.4

2.7

198.70

230.44

e6/l

1.48

143

859

Presence of other devices

107

547

1.93

9.39

2.4

2.1

215.58

233.73

e6/l

0.37

100

471

Hypopituitarism

280

2.35

9.34

2.8

3.2

184.56

201.65

e6/l

0.40

234

Other arrhythmias

328

1683

1.46

9.32

2.4

2.8

225.66

241.84

e6/l

0.75

275

1425

Other CVD

462

2.02

9.31

1.9

2.4

246.04

238.09

e6/l

0.09

411

Perforation of tympanic membrane

268

2.37

9.30

2.6

2.7

219.22

212.42

e6/l

0.12

229

Haemorrhoids and perianal venous thrombosis

155

899

1.72

9.29

2.1

2.6

226.20

244.24

e6/l

0.58

134

769

Psychiatric diseases

509

1870

1.37

9.27

2.9

2.6

210.16

232.66

e6/l

1.73

425

1567

Malignant neoplasm of endocrine gland, including Hilmo

146

2.90

9.27

3.7

2.1

238.06

216.10

e6/l

0.30

124

Diseases of oral cavity, salivary glands and jaws

248

816

1.57

9.26

2.5

2.4

213.14

252.68

e6/l

2.05

202

698

Thyroiditis, ILD-related definition

275

2.34

9.23

2.0

2.5

201.19

214.59

e6/l

0.24

216

Other diseases of the digestive system

152

886

1.72

9.21

2.4

2.7

223.14

238.56

e6/l

0.27

133

751

Other disorders starting during childhood or adolecense, excluding more controls

210

2.53

9.20

4.8

2.8

189.00

215.39

e6/l

0.41

147

Spinal stenosis

220

1026

1.58

9.19

2.2

2.5

230.91

233.74

e6/l

0.08

197

891

Tuberculosis

105

3.27

9.17

1.6

2.2

246.14

229.58

e6/l

0.12

Crohn disease (strict definition, require KELA, min 2 HDR)

198

2.61

9.16

2.0

3.2

130.24

220.61

e6/l

5.13

169

Other diseases of hard tissues of teeth

246

815

1.57

9.15

2.5

2.4

194.96

252.50

e6/l

3.92

195

697

Varicella [chickenpox]

153

2.85

9.14

2.3

3.0

198.61

222.57

e6/l

0.26

127

Other noninfective disorders of lymphatic vessels and lymph nodes

3.63

9.13

2.1

2.3

206.62

224.96

e6/l

0.23

Bacterial, viral and other infectious agents, including avohilmo

277

2.33

9.10

2.7

3.2

254.09

224.36

e6/l

0.51

239

Injuries to the abdomen, lower back, lumbar spine and pelvis

209

1308

1.58

9.03

2.4

2.7

244.93

227.88

e6/l

0.47

178

1107

Focal epilepsy

130

729

1.79

9.02

2.4

2.9

210.54

220.81

e6/l

0.23

106

600

Malignant neoplasm of endocrine gland

127

3.02

9.00

3.4

2.1

243.33

205.58

e6/l

0.55

107

Hypertension, essential

395

1587

1.41

8.92

2.3

2.8

235.79

235.58

e6/l

0.01

335

1342

Injuries to the ankle and foot

411

2542

1.38

8.90

2.4

2.8

211.62

225.77

e6/l

0.85

338

2115

Crohn disease (strict definition, require KELA)

201

2.57

8.89

2.0

3.2

130.24

219.72

e6/l

5.06

170

Bacterial, viral and other infectious agents

249

2.39

8.89

2.8

3.2

254.63

222.76

e6/l

0.52

217

Need for immunization against other single viral diseases

4.57

8.88

1.2

2.3

209.60

206.68

e6/l

0.02

Bell's palsy

299

2.26

8.87

3.3

2.6

210.83

225.68

e6/l

0.23

251

GI-bleeding

149

875

1.71

8.80

2.4

2.7

225.55

239.40

e6/l

0.24

130

743

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

214

2.50

8.78

1.6

2.4

223.04

213.16

e6/l

0.16

188

Polyarthrosis

398

2.02

8.78

2.2

2.8

203.22

242.77

e6/l

1.19

348

Pain in thoracic spine

425

2.03

8.77

2.2

2.7

218.82

218.79

e6/l

0.00

360

Malnutrition

3.73

8.77

3.7

3.3

221.52

174.33

e6/l

0.43

Allergic purpura

3.71

8.75

2.1

2.6

194.29

233.12

e6/l

0.38

Phlebitis and thrombophlebitis (not including DVT)

118

650

1.82

8.71

2.5

2.6

232.01

229.87

e6/l

0.04

566

Vulvovaginal ulceration/inflammation in other diseases

209

2.51

8.71

2.6

2.4

185.00

205.47

e6/l

0.47

168

Abnormal serum enzyme levels

146

825

1.71

8.68

2.2

2.7

204.69

246.23

e6/l

1.76

118

726

Human immunodeficiency virus [HIV] disease resulting in other conditions

4.49

8.67

3.9

2.7

335.47

236.60

e6/l

0.99

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

123

667

1.80

8.66

2.4

3.1

222.62

208.81

e6/l

0.31

523

Other female pelvic inflammatory diseases

441

2.01

8.65

2.2

2.5

204.72

218.27

e6/l

0.34

366

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

190

1194

1.60

8.64

2.5

2.8

214.27

228.87

e6/l

0.54

150

1001

Rosacea

381

2.09

8.62

2.3

2.6

215.79

224.53

e6/l

0.14

321

Hypertensive diseases

420

1712

1.39

8.62

2.3

2.8

219.05

234.06

e6/l

0.67

348

1423

Hypertension

419

1707

1.39

8.62

2.3

2.8

219.69

234.16

e6/l

0.63

347

1418

Other obstetric conditions, not elsewhere classified

196

770

1.61

8.56

2.1

2.5

188.89

229.95

e6/l

2.42

164

622

Gout, strict definition

423

2.02

8.52

2.7

2.3

240.81

239.75

e6/l

0.01

375

Benign neoplasm of eye and adnexa

254

2.34

8.51

2.4

237.10

217.62

e6/l

0.33

224

Intestinal adhesions without obstruction

165

2.69

8.46

2.4

2.6

224.56

223.34

e6/l

0.01

145

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

4.39

8.46

3.9

2.7

335.47

235.28

e6/l

1.01

Scleritis and episcleritis

166

2.68

8.39

2.5

236.82

224.64

e6/l

0.14

139

Other peripheral vascular diseases

201

2.51

8.38

1.6

2.6

179.41

218.55

e6/l

1.07

176

Other endocrine disorders

269

2.28

8.37

5.4

3.2

175.19

203.06

e6/l

0.50

193

Chronic apical periodontitis

568

2424

1.32

8.32

2.6

2.5

211.02

234.20

e6/l

2.06

483

2037

Sensorineural hearing loss

349

1648

1.41

8.32

2.4

2.7

251.12

226.02

e6/l

1.10

311

1413

Pyothorax

3.24

8.23

1.7

2.5

292.36

228.48

e6/l

0.34

Unspecified haematuria

193

996

1.58

8.21

2.6

263.76

234.29

e6/l

0.70

162

866

Crossbite

338

2.09

8.20

3.1

3.4

219.86

192.02

e6/l

0.54

262

Pain and other conditions associated with female genital organs and menstrual cycle

125

592

1.77

8.19

2.1

2.2

219.52

207.30

e6/l

0.33

105

490

Hard cardiovascular diseases

426

1843

1.37

8.18

2.1

2.9

228.17

236.70

e6/l

0.30

369

1544

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

216

2.43

8.15

2.0

3.2

131.60

215.62

e6/l

4.73

180

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

109

600

1.83

8.11

2.1

2.8

180.35

226.47

e6/l

1.31

500

Juvenile arthritis (FINNGEN)

152

2.73

8.11

2.1

3.9

152.17

194.35

e6/l

1.37

130

Focal epilepsy, mode (most common among epilepsy diagnosis)

111

615

1.81

8.08

2.4

3.0

212.48

215.22

e6/l

0.05

502

Strabismus

168

1040

1.62

8.08

3.0

2.9

223.77

224.93

e6/l

0.02

144

839

Volume depletion

223

2.39

8.06

1.7

2.8

148.98

237.54

e6/l

3.20

190

Cardiomyopathy

412

2.00

8.01

2.3

3.0

168.86

254.63

e6/l

2.59

354

Varicella [chickenpox], including avohilmo

212

2.44

7.99

3.2

3.1

178.60

215.82

e6/l

0.55

170

Congenital malformations of trachea and bronchus

4.81

7.96

3.1

4.2

366.23

218.00

e6/l

0.66

Substance use, excluding alcohol

119

677

1.77

7.94

2.3

2.8

238.31

230.18

e6/l

0.12

103

563

DVT of lower extremities

476

1.92

7.94

2.3

2.5

237.36

230.63

e6/l

0.11

418

Otalgia

269

2.25

7.91

3.4

2.8

213.11

183.69

e6/l

0.57

218

Seborrhoeic dermatitis

244

2.31

7.89

2.1

2.7

273.20

232.74

e6/l

0.36

209

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

534

1.86

7.88

2.1

2.6

180.67

225.29

e6/l

1.14

444

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

162

871

1.63

7.85

2.6

2.9

189.29

214.61

e6/l

1.15

123

670

Valvular heart disease excluding rheumatic fever

224

1055

1.52

7.83

2.3

2.9

191.41

244.18

e6/l

3.90

195

907

Other specified/unspecified bacterial intestinal infections

149

2.71

7.83

2.4

2.6

273.80

212.98

e6/l

0.60

131

Nonpyogenic thrombosis of intracranial venous system

6.61

7.81

2.2

2.1

144.43

191.42

e6/l

0.57

Other diseases of liver

101

550

1.85

7.80

2.2

2.9

226.63

234.22

e6/l

0.10

462

Malignant neoplasm of bladder, including Hilmo

125

2.85

7.79

2.4

1.4

267.23

240.57

e6/l

0.22

111

Other congenital malformations, not elsewhere classified

4.52

7.79

1.8

5.1

162.43

170.39

e6/l

0.08

Other disorders of conjunctiva

356

2.06

7.78

2.2

2.7

203.77

236.48

e6/l

0.82

310

Ulcerative colitis (strict definition, require KELA)

102

558

1.84

7.77

2.1

2.6

180.70

226.93

e6/l

1.24

464

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

189

754

1.58

7.74

2.2

2.5

187.03

230.29

e6/l

2.55

158

611

Juvenile rheumatoid arthirtis

3.93

7.73

2.4

2.9

151.81

211.45

e6/l

1.07

Pyogenic arthritis

139

2.76

7.70

1.8

2.8

226.41

229.61

e6/l

0.03

121

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

186

2.52

7.67

3.7

287.85

194.77

e6/l

1.18

135

Otitis externa, unspecified

365

2.04

7.66

2.6

3.0

246.00

209.16

e6/l

0.83

296

Sleep apnoea

466

2208

1.33

7.65

2.2

2.7

256.60

230.22

e6/l

1.61

404

1854

Acute bronchiolitis

298

2.12

7.64

3.2

3.5

199.46

181.96

e6/l

0.26

203

Corns and callosities

140

2.74

7.60

1.6

2.2

221.67

197.30

e6/l

0.27

121

Ascites

140

2.73

7.60

2.1

2.5

155.56

241.61

e6/l

2.13

118

Other external causes of accidental injury

430

1593

1.35

7.56

2.5

2.8

221.40

234.51

e6/l

0.61

359

1322

Vitamin B12 deficiency anaemia

193

2.45

7.55

2.0

2.2

212.54

209.71

e6/l

0.03

167

Diseases of external ear

193

1258

1.54

7.55

2.6

2.8

261.77

227.43

e6/l

0.53

163

1063

Non-rheumatic valve diseases

217

1023

1.52

7.55

2.3

2.8

192.46

245.04

e6/l

3.74

191

880

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

341

2.07

7.55

3.0

3.3

199.66

216.61

e6/l

0.31

253

Delayed milestone in childhood

196

2.44

7.55

3.5

4.2

203.31

200.99

e6/l

0.02

130

Viral hepatitis, IBD co-morbidity

3.49

7.54

2.4

2.7

163.06

213.25

e6/l

0.80

Congenital malformations and deformations of the musculoskeletal system

434

1.94

7.53

2.3

3.0

227.48

207.53

e6/l

0.42

327

Chondropathies

464

1.91

7.53

3.5

2.7

228.62

216.59

e6/l

0.24

381

Tooth eruption problems

112

614

1.77

7.52

3.4

3.0

186.26

205.74

e6/l

0.60

487

Retinal detachments and breaks

156

970

1.61

7.48

2.2

2.6

216.55

237.46

e6/l

0.74

134

845

Other diseases of stomach and duodenum

119

2.88

7.48

2.2

2.4

167.81

213.48

e6/l

0.87

105

Gingival hyperplasia

142

2.72

7.45

4.3

3.3

273.58

202.30

e6/l

0.20

116

Irregular menses

255

1314

1.46

7.45

2.9

2.4

211.55

215.79

e6/l

0.14

219

1084

STROKE

271

1263

1.45

7.41

2.4

2.9

240.01

237.82

e6/l

0.05

237

1080

Malignant neoplasm of urinary organs, including Hilmo

142

2.69

7.39

2.9

1.6

279.52

236.98

e6/l

0.27

129

Diseases of peritoneum

239

2.27

7.36

2.3

2.4

217.88

214.58

e6/l

0.04

205

Anogenital herpesviral [herpes simplex] infection

202

2.40

7.35

2.7

2.6

179.75

212.62

e6/l

0.80

165

Spondylopathies (FG)

371

2.01

7.34

1.9

3.0

240.71

235.41

e6/l

0.08

315

Transport accidents

249

1424

1.46

7.33

2.2

2.8

230.04

230.57

e6/l

0.01

203

1186

Adverse effects, not elsewhere classified

123

725

1.71

7.29

2.0

2.8

227.65

214.53

e6/l

0.33

584

Other disorders of patella

498

1.86

7.27

2.5

2.9

205.05

238.64

e6/l

1.00

418

Atopic dermatitis, strict definition

195

1256

1.52

7.27

2.4

2.9

211.60

220.23

e6/l

0.25

160

996

Dermatophytosis

366

2.01

7.24

2.5

3.0

233.00

223.22

e6/l

0.16

314

Disorders resulting from impaired renal tubular function

100

3.04

7.22

1.7

2.7

162.00

197.61

e6/l

0.32

Spondylolisthesis/Spondylolysis

485

1.86

7.22

1.8

2.9

223.41

229.02

e6/l

0.11

426

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

127

2.77

7.21

2.9

1.6

272.82

221.96

e6/l

0.31

114

Disorders of vitreous body and globe

231

1490

1.47

7.20

2.6

2.5

245.52

232.50

e6/l

0.40

199

1296

Motor disorders, excluding more controls

104

2.99

7.17

3.6

2.9

278.17

230.98

e6/l

0.27

Atrial fibrillation and flutter with reimbursement

112

397

1.78

7.17

2.4

3.1

252.71

237.53

e6/l

0.21

350

Persons with potential health hazards related to communicable diseases

235

1599

1.46

7.15

3.1

2.7

228.74

222.29

e6/l

0.18

168

1293

Abscess of anal and rectal regions

236

2.26

7.14

1.9

3.3

171.85

229.34

e6/l

1.47

202

Panniculitis affecting regions of neck and back

3.37

7.12

1.6

2.4

216.24

214.77

e6/l

0.01

Nonorganic sleeping disorders, excluding more controls

111

643

1.73

7.01

1.7

2.6

243.75

233.67

e6/l

0.17

517

Trigeminal neuralgia

118

2.82

7.00

2.8

2.6

247.15

203.67

e6/l

0.66

100

Dystonia

135

2.69

7.00

3.2

2.4

212.84

212.89

e6/l

0.00

112

Other bursopathies

330

2.04

6.99

2.3

2.9

231.89

227.06

e6/l

0.07

287

Golimumab

102

2.98

6.98

1.3

3.1

293.21

216.57

e6/l

0.90

Hypersensitivity pneumonitis due to organic dust

5.95

6.96

2.3

2.2

173.39

172.31

e6/l

0.01

Anomalies of dental arch relationship, including avohilmo

131

717

1.66

6.94

3.3

2.8

197.10

218.00

e6/l

0.74

113

573

Hypotension

372

1.97

6.92

1.8

2.2

247.49

234.80

e6/l

0.12

332

Disorders of continuity of bone

272

2.15

6.90

3.2

2.6

200.72

205.00

e6/l

0.06

226

Other Crohn's disease

196

2.37

6.87

2.1

2.9

151.84

227.52

e6/l

2.51

164

Other and unspecified rosacea

240

2.22

6.87

2.4

2.8

215.56

220.87

e6/l

0.06

208

External causes of morbidity and mortality

335

1213

1.39

6.86

2.5

2.6

215.08

228.62

e6/l

0.58

279

992

Alopecia areata

3.38

6.85

2.5

3.3

223.81

204.65

e6/l

0.22

Melanocytic naevi

169

1095

1.55

6.85

2.6

2.7

202.50

228.97

e6/l

1.23

141

923

Other benign neoplasms of skin

174

1135

1.54

6.83

2.1

2.6

230.96

231.41

e6/l

0.01

147

977

Disorders of vitreous body

224

1464

1.46

6.77

2.6

2.5

245.64

232.54

e6/l

0.39

193

1271

Psoriasis vulgaris

562

1.77

6.73

2.5

2.7

184.24

235.66

e6/l

2.70

479

Soft tissue disorders related to use, overuse and pressure

131

803

1.64

6.71

1.9

2.7

205.18

234.27

e6/l

1.20

114

692

Total colectomy operation

2.96

6.71

2.7

3.0

222.70

233.87

e6/l

0.09

Total colectomy

2.96

6.71

2.7

3.0

222.70

233.87

e6/l

0.09

Malignant neoplasm of digestive organs

117

526

1.70

6.70

2.1

1.9

265.78

232.29

e6/l

0.52

102

455

Other juvenile arthritis

145

2.58

6.63

2.2

3.9

156.96

180.30

e6/l

0.56

122

Chronic suppurative otitis media, including avohilmo

251

2.17

6.59

2.4

2.9

213.43

215.23

e6/l

0.03

200

Heart failure and coronary heart disease

175

797

1.54

6.59

2.2

2.5

201.68

241.05

e6/l

1.33

158

687

Disease of hard tissues of teeth, NOS

224

794

1.48

6.59

2.4

221.07

248.91

e6/l

1.22

182

683

Hallux valgus (acquired)

141

625

1.62

6.54

2.2

2.6

220.57

236.86

e6/l

0.42

124

534

Inflammatory disease of uterus

437

1.86

6.52

1.7

2.6

230.78

219.25

e6/l

0.23

352

Coeliac disease

388

1.92

6.51

3.2

2.9

178.15

211.04

e6/l

0.98

314

Other predominantly sexually transmitted diseases, not elsewhere classified

101

584

1.74

6.47

2.6

2.5

217.40

219.04

e6/l

0.03

468

Falls/tendency to fall

569

2243

1.27

6.46

2.5

2.7

219.84

230.03

e6/l

0.54

476

1854

Short stature, not elsewhere classified

206

2.27

6.39

6.1

3.4

176.27

204.00

e6/l

0.41

139

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

284

1973

1.38

6.36

2.5

2.6

203.09

221.93

e6/l

1.13

231

1642

Excessive attrition of teeth

325

2389

1.35

6.30

2.4

2.7

211.79

226.54

e6/l

0.80

256

2010

Malignant melanoma

223

2.21

6.29

3.6

1.8

260.00

228.18

e6/l

0.47

196

Accidents

419

1593

1.32

6.29

2.6

2.8

221.04

234.51

e6/l

0.62

346

1322

Other ulcerative colitis

155

2.47

6.27

2.0

2.7

209.57

226.51

e6/l

0.17

134

Malignant melanoma, including Hilmo

256

2.12

6.27

3.4

2.0

257.07

228.62

e6/l

0.47

221

Otitis externa

127

789

1.62

6.21

2.6

2.8

277.43

222.22

e6/l

0.60

107

653

Infections with a predominantly sexual mode of transmission, including avohilmo

222

1417

1.44

6.20

2.5

2.6

205.16

221.06

e6/l

0.67

180

1165

Non-selective monoamine reuptake inhibitors

166

1051

1.52

6.19

2.0

2.5

232.20

238.86

e6/l

0.17

139

918

Special screening examination for other diseases and disorders

193

2.29

6.16

2.7

2.2

206.49

253.19

e6/l

0.99

161

Sleep disorders (combined)

553

2283

1.27

6.14

2.2

2.7

242.70

225.95

e6/l

0.97

470

1920

Chronic suppurative otitis media

175

2.36

6.14

2.6

225.44

219.54

e6/l

0.08

143

Metatarsalgia

259

2.10

6.11

2.2

3.1

255.84

205.85

e6/l

1.06

218

Other disorders of central nervous system

5.30

6.06

3.5

2.0

207.50

200.22

e6/l

0.05

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

512

1.76

6.02

2.3

2.9

228.77

209.33

e6/l

0.42

389

Heartburn

261

2.08

5.99

2.3

2.9

237.13

230.99

e6/l

0.07

220

Other arthrosis

224

1047

1.44

5.98

1.8

2.8

242.53

244.14

e6/l

0.03

194

898

Restless leg syndrome

400

1.86

5.96

2.4

2.5

215.70

218.33

e6/l

0.05

340

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS